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Abstract 
Genomic copy number alterations (CNA) and loss of heterozygozity (LOH) are two types of genomic 
instabilities associated with cancer. Acquisition of these genomic instabilities affects the expression 
level of oncogenes and tumor suppressor genes. Thus, accurate detection of these abnormalities is a 
crucial step in identifying novel oncogenes and tumor suppressor genes. Whole-genome sequencing 
of tumor tissues has enabled new opportunities for the detection of such aberrations and the 
characterization of genomic aberrations in tumor samples.  
In this work, a fast tool for the identification of CNAs and copy-neutral LOH in tumor samples using 
whole-genome sequencing data was developed. The developed tool segments the genome by 
analyzing the read-depth and B-allele fraction profiles using a double sliding window method. It 
requires a matched normal sample to correct for biases such as GC-content and mapability and to 
discriminate somatic from germline events. The developed tool was evaluated on both simulated and 
real whole-genome sequencing data against competing, state of the art tools to demonstrate its 
accuracy. The tool, written in the Python programming language, is fast and performs segmentation 
of a whole genome in less than two minutes.  
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1. Introduction 
Cancer is a major human health problem and a leading cause of death worldwide. Any attempt 
towards the prevention or treatment of cancer requires a deep understanding of the processes 
underlying the initiation, development and dissemination of the cancer. It is widely accepted that 
cancer is a disease subject to Darwinian evolution. Cancer arises from a single cell by the introduction 
of a single mutation. The mutation, if selected naturally, is passed to the daughter cells through cell 
division. As time passes, more and more mutations occur and accumulate. This results in 
heterogeneous and genetically diverse populations of cancer cells (Nowell 1976, Marusyk, Polyak 
2010). Mutations are divided into two groups depending on the cell type in which they occur. If a 
mutation occurs in reproductive cells (eggs and sperms), it is called a germ-line mutation. Germ-line 
mutations can pass on to the next generation. In contrast, if a mutation occurs in non-reproductive 
cells, it is called a somatic mutation. Somatic mutations affect only the individual in which they occur 
and thus they are not transmitted to future generations.  
In the past several years, advances in sequencing technology such as the introduction of high 
throughput sequencing (HTS) have enabled more in depth study of cancer in terms of detecting 
genomic alterations. HTS technologies allow determining the exact order of nucleotides present in a 
given DNA or RNA molecule much more quickly and cheaply than older technologies such as Sanger 
sequencing. As a result, they facilitate efficient and economic genome-wide production of huge 
amount of data on DNA, mRNA and epigenetic level. HTS data has been used to identify genomic 
alterations such as nucleotide substitutions, small insertions and deletions, copy number alterations 
and chromosomal rearrangements in cancer cells. As a result, the knowledge of the underlying 
mechanisms of cancer has substantially increased. 
Copy number alterations (CNA) and loss of heterozygosity (LOH) events are two types of genomic 
alterations associated with cancer. Copy number is defined as the number of copies per cell of a 
particular gene or other DNA sequence. Normally, diploid organisms such as humans have two copies 
of each autosomal DNA sequence. A CNA is an event where one copy of a genomic region is either 
gained or lost. CNA denotes somatically acquired copy number changes in the genome. In contrast, 
copy number variation (CNV) denotes the differences among individuals in the number of copies of 
a region of the genome. It is now known that the CNAs affect the expression level of genes (Curtis, 
Shah et al. 2012). Consequently, these differences in expression levels drive differences in clinical 
behavior of cancer and in susceptibility to treatments (Yakhini, Jurisica 2011). 
LOH is an event in which one of two alleles at a heterozygous locus is lost due to segmental 
aneuploidies or some other mechanisms such as gene conversion, mitotic recombination, and mitotic 
nondisjunction (Ha, Roth et al. 2012). These events can be identified by examining the heterozygous 
alleles in normal cells that have become homozygous in the tumor cells. LOH events have been 
observed in many types of cancer at genomic regions of tumor suppressor genes such as PTEN, RB1 
and TP53. Genomic allelic losses caused by LOH events can affect the expression of genes. For 
instance, monoallelic expression can arise as a result of genomic allelic loss via LOH events (Ha, 
Roth et al. 2012). Monoallelic expression is the expression of a gene from only one of two alleles in 
a diploid organism. This can occur, for example, when the wild-type allele is replaced by the mutant 
allele. The altered expression of genes with allelic imbalance due to a LOH event may bring about 
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selective advantages for tumorigenesis and progression. By analyzing a cohort of 23 triple-negative 
breast cancer (TNBC) patients, Ha et al. (2012) have shown that LOH is a prominent feature of TNBC 
somatic aberrations and modulates a significant portion of the transcriptome in the form of 
monoallelic expression (Ha, Roth et al. 2012).  
Hence, detection and characterization of events such as CNAs and LOH are crucial in learning more 
about the fundamental mechanisms of cancer, identification of prospective cancer related genes and 
eventually in prevention and treatment of cancer.  
Traditionally, cytogenetic technologies such as fluorescence in situ hybridization (FISH) were used 
to identify copy number variations (CNVs). In 1992, Kallioniemi et al. introduced comparative 
genomic hybridization (CGH) for detecting CNAs in tumor samples (Kallioniemi, Kallioniemi et al. 
1992). The introduction of array-based technologies such as arrayCGH (or aCGH) made the genome-
wide detection of such aberrations possible. However, these methods were unable to detect copy-
neutral LOH events. Single-nucleotide polymorphism (SNP) arrays overcame this limitation by 
providing the ability to identify both CNAs and LOH (Speicher, Carter 2005). SNP refers to single-
base difference in DNA among individuals. However, these methods suffered from certain drawbacks 
such as hybridization noise, limited genome coverage and low resolution (Zhao, Wang et al. 2013). 
The introduction of HTS such as whole exome sequencing (WES) and whole genome sequencing 
(WGS) has overcome certain drawbacks of the previous methods. HTS-based detection approaches 
have several advantages such as including higher coverage and resolution, more accurate copy 
numbers estimation and more precise breakpoints detection (Zhao, Wang et al. 2013). These 
advantages nominate HTS-based detection as an efficient approach for studying cancer genomes.  
Although there are several tools available capable of detecting CNAs and LOH events, only few of 
them utilize WGS data for the detection of such aberrations (Yu, Liu et al. 2014, Mayrhofer, 
DiLorenzo et al. 2013, Boeva, Popova et al. 2012). In addition, some of these tools require the users 
to create configuration files and to set several parameters prior to running the analysis where the 
setting of some parameters might require some prior knowledge about the data. For instance, 
ControlFREEC (a CNA and LOH detection tool) requires the users to set a value for ploidy of the 
tumor (Boeva, Popova et al. 2012a). If this value is not known, user is required to run the analysis 
few times with different values for ploidy. Furthermore, some of the tools’ runtime can take up to 
few hours. 
Thus, the main idea of this thesis is to develop a fast and easy-to-use tool that utilizes WGS data 
resulting from sequencing of tumor and normal samples in order to detect and segment regions of the 
genome with CNAs and copy-neutral LOH events. In this thesis, the implementation of this tool is 
explained. 
In chapter 2, the biological and technical background required for understanding this thesis will be 
explained. The chapter continues with a literature review providing an overview of the methods used 
to perform somatic copy number analysis and their advantages and disadvantages. 
Chapter 3 explains the main research objectives of this research. Furthermore, steps taken to fulfill 
the main objective of this research will be explained in this chapter.   
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Chapter 4 explains the materials and methods used to implement the tool. Furthermore, in this chapter, 
the implementation of a simulator capable of simulating the normal and the cancer genome with 
events such as deletion, amplification and copy-neutral LOH is explained. 
In chapter 5, first, the results from the analysis of some WGS tumor data using the developed tool 
will be visualized in integrative genomics viewer (IGV). Next, the tool is benchmarked against three 
other competing, somatic copy number analysis tools and the results of the benchmark will be 
presented.  
In chapter 6, a discussion about this work will be provided, some of the limitations of the developed 
tool will be discussed, and the future work required to address the limitations will be described. 
Finally, chapter 7 concludes the thesis.   
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2. Review of Literature 
Cancer is a major human health problem and a leading cause of death worldwide. According to the 
International Agency for Research on Cancer (IARC), cancer accounted for 8.2 million deaths 
worldwide in 2012. In the same year, 32.6 million people worldwide were living with cancer 
(Globocan.iarc.fr 2014). Figure 2.1 illustrates the estimated age-standardized incidence and mortality 
rates worldwide for both females and males. Furthermore, figure 2.2 illustrates the mortality rates 
caused by different types of cancer for females and males. 
 
Figure 2.1 Estimated age-standardized incidence and mortality rates worldwide for both females and males (adapted from 
globocan.iarc.fr 2014). 
 
Figure 2.2 Mortality rates caused by different types of cancer worldwide. (A) Female mortality rates (B) Male mortality rates 
(adapted from globocan.iarc.fr 2014). 
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Over the past few decades, our understanding and knowledge of the underlying processes of cancer 
has expanded remarkably. It is now known that cancer arises from a single cell. Cancer can be 
subdivided into a variety of distinct types caused by mutated genes (Martinez, Taylor Parker et al. 
2003). In 2000, Hanahan and Weinberg described the rules that govern the transformation of normal 
human cells into cancer cells as a multistep process. According to them, tumor development is subject 
to Darwinian evolution where the successive selection of deleterious genetic changes in normal cells 
and their passage to the daughter cells causes the accumulation of such changes and leads to 
progressive conversion of normal cells to cancer cells (Hanahan, Weinberg 2000). They have listed 
six essential alterations in cell physiology that together dictate malignant growth. These six 
capabilities are shared by most and perhaps all types of human tumors. They call these capabilities 
“the hallmarks of cancer” where hallmark refers to: “the acquired functional capabilities that allow 
cancer cells to survive, proliferate, and disseminate” (Hanahan, Weinberg 2000). These six hallmarks 
are self-sufficiency in growth signals, insensitivity to growth-inhibitory (antigrowth) signals, evasion 
of programmed cell death (apoptosis), limitless replicative potential, sustained angiogenesis, and 
tissue invasion and metastasis. Figure 2.3 illustrates these acquired capabilities of cancer. 
In 2011, Hanahan and Weinberg expanded their original model by adding four more capabilities, 
which are avoidance of immune destruction, deregulation of cellular energetics, genome instability 
and mutation, and tumor-promoting inflammation (Hanahan, Weinberg 2011). Figure 2.4 illustrates 
the expanded model of acquired capabilities of cancer. 
 
 
Figure 2.3 Acquired capabilities of cancer (adapted from Hanahan and Weinberg, 2000). 
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Figure 2.4 Expanded model of acquired capabilities of cancer (adapted from Hanahan and Weinberg, 2011). 
Of all these hallmarks, genome instability and mutation is the most consistent hallmark found in all 
cancers (Dancey, Bedard et al. 2012). According to Hanahan and Weinberg, the genome instability 
is the source of chromosomal rearrangements (Hanahan, Weinberg 2011). 
2.1. Chromosomal Rearrangement 
Chromosomal rearrangements are present in many cancers. Usually, a chromosomal rearrangement 
is caused by breakage of DNA double helices in the genome at two different locations. Subsequently, 
the broken ends are rejoined to produce a new chromosomal arrangement that is different from the 
original nucleotide sequence (Griffiths, Gelbart et al. 1998). However, not all the chromosomal 
rearrangements need breakage at two different locations. For instance, terminal deletion requires a 
single breakage followed by the capping of the broken end with a telomere (Moore, Best 2001). 
Chromosomal rearrangement is subdivided into several classes of events such as deletion, 
duplication, inversion and translocation. Figure 2.5 illustrates different classes of chromosomal 
rearrangement. 
Deletion, a class of chromosomal rearrangement, is the result of the loss of one region of a 
chromosome. In a deletion event, there are two chromosome breaks where the intervening segment 
is lost and subsequently the two ends are rejoined. Deletion itself can be categorized into two different 
types: hemizygous deletion and homozygous deletion. Hemizygous deletion occurs when a diploid 
organism loses one allele or portion of an allele from its genome. In contrast, homozygous deletion 
occurs when both copies of the same allele or the same chromosomal segment of a pair of homologous 
chromosomes is lost (Encyclopedic reference of cancer. 2001). Dong (2001) describes mechanisms 
through which deletion can inactivate tumor suppressor genes leading to carcinogenesis. Tumor 
 7 
suppressor genes are mainly involved in constraining cells from uncontrolled growth and migration. 
As an example, hemizygous deletion induces haploinsufficiency that is a condition where the 
remaining functional copy of a gene (after a hemizygous deletion) is not capable of producing enough 
gene product to bring about a wild-type condition (Dong 2001). For instance, Cristofano et al. (1998) 
have demonstrated the causal role of PTEN haploinsufficiency in Cowden disease, Lhermitte-Duclos 
disease and Bannayan-Zonana syndrome (Di Cristofano, Pesce et al. 1998). The deletion event has 
been observed in several other cancer-related genes such as RB1, CDKN2A/B, ARID1A, MAP2K4, 
NF1, SMAD4, BRCA1/2, MSH2/6, DCC and CDH1 (Liu, Morrison et al. 2013). 
In duplication, another class of chromosomal rearrangement, an extra copy of a chromosomal region 
is produced. The duplication event has been observed in several cancer-related genes such as ERBB2, 
EGFR, MYC, PIK3CA, IGF1R, FGFR1/2, KRAS, CDK4, CCND1, MDM2, MET, CDK6 (Liu, 
Morrison et al. 2013). As an example, the duplication of ERBB2 oncogene, observed in 20-30% of 
human breast cancers, leads to the overexpression of its gene product resulting in rapid cell 
proliferation (Isola, Chu et al. 1999). 
 
 
Figure 2.5 Different classes of chromosomal rearrangement. 
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In an inversion event, one chromosome region is inverted. In this class of event, there are two 
chromosome breaks followed by the inversion of the intervening segment and subsequently the 
rejoining of the broken ends. For instance, in a subset of parathyroid adenomas, an inversion event in 
chromosome 11 places the PTH gene transcriptional regulatory sequences upstream of Cyclin D1 
gene that results in unregulated Cyclin D1 overexpression and enhanced cell proliferation (Hemmer, 
Wasenius et al. 2001).  
A translocation event takes place when two nonhomologous chromosomes exchange chromosomal 
segments. In this class of event, two chromosome breaks take place in two different chromosomes, 
which is followed by the exchange of segments between two chromosomes and subsequently the 
broken ends are rejoined (Griffiths, Gelbart et al. 1998). Rowley (2001) describes two mechanisms 
where translocation plays a role in cancer. In the first mechanism, promoter/enhancer elements of a 
gene are juxtaposed with the coding region of another gene. For instance, in Burkitt’s lymphoma, the 
promoter of IGH gene on chromosome 14 is juxtaposed with the MYC gene on chromosome 8 that 
results in the overexpression of MYC. In the second mechanism, translocation results in the 
juxtaposition of the coding regions of two different genes. For instance, in chronic myeloid leukemia, 
the coding region of BCR gene on chromosome 22 is juxtaposed with the coding region of ABL gene 
on chromosome 9 resulting in a fusion gene capable of activating signaling pathways involved in cell 
growth and proliferation (Rowley 2001).  
Copy number is defined as the number of copies per cell of a particular gene or other DNA sequence 
(Encyclopedic dictionary of polymers. 2011). Chromosomal rearrangement events such as deletion 
and duplication may change the copy number of a gene. Consequently, the expression level of genes 
is often correlated with its copy number (Curtis, Shah et al. 2012) - a phenomenon known as gene 
dosage effect. Normally, diploid organisms such as humans have two copies of each autosomal DNA 
sequence. Somatic copy number changes are known as copy number alterations (CNA). CNAs should 
be distinguished from copy number variations (CNV). CNA is defined as a sequence that is found at 
different copy numbers in an individual’s germline DNA and in the DNA of a clonal sub-population 
of cells. On the other hand, CNV is defined as a DNA sequence that is found at different copy numbers 
in the germline DNA of two different individuals. Normally, an amplification or deletion event of 
size 50 base pair or greater is defined as CNV (Beroukhim, Mermel et al. 2010). 
Loss of heterozygosity (LOH) is an event in which one of two alleles at a heterozygous locus is lost. 
Subsequently, the lost allele may be discarded or replaced with a duplicated copy of the surviving 
allele (Weinberg 2013). Copy-neutral LOH occurs if the lost allele is replaced with a duplicated copy 
of the surviving allele. As a result, the copy number remains unchanged.  
Mosén-Ansorena, Aransay and Rodríguez-Ezpeleta (2012) enumerate copy number alterations and 
loss of heterozygozity (LOH) events as two genomic instabilities associated with cancer (Mosén-
Ansorena, Aransay et al. 2012). These events affect the expression of oncogenes and tumor 
suppressor genes through the mechanisms explained earlier (Pinkel, Segraves et al. 1998, Curtis, Shah 
et al. 2012, Ha, Roth et al. 2012). Oncogenes and tumor suppressor genes are two important groups 
of genes with respect to cancer. Oncogenes are normally responsible for cell growth. On the other 
hand, tumor suppressor genes are responsible for constraining cell proliferation. DNA mutations in 
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oncogenes may result in gain of function and mutations in tumor suppressor genes may result in loss 
of function. Cancer cells, carrying the oncogenic and tumor suppressor mutations, initiate 
tumorigenesis and drive tumor progression forward (Hanahan, Weinberg 2000). Hence, accurate 
detection and characterization of events such as CNAs and LOH are crucial in the discovery of 
prospective cancer-related genes such as novel oncogenes and tumor suppressor genes. These 
discoveries are important in the understanding of tumor growth, tumor aggression, and treatment 
failure and in devising new therapeutic approaches. 
2.2. Detection Methods 
In the past decades, several methods have been used for the detection of chromosomal aberrations, 
including CNAs and LOH. These methods have different throughputs, coverages and resolutions. 
Fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), array CGH, 
single nucleotide polymorphism (SNP) arrays, and HTS-based detection are among the mostly used 
detection methods.     
2.2.1. Fluorescence in Situ Hybridization (FISH) 
Weinberg (2013) defines Fluorescence in Situ Hybridization (FISH) as a procedure in which a 
sequence-specific DNA probe linked to a fluorescent chromophore is annealed to the DNA or RNA 
of cells that have been immobilized on a microscope slide. As a result, fluorescing spots reveal the 
presence and often the number of copies of homologous DNA sequences carried by such cells 
(Weinberg 2013). FISH helps to visualize and map the genetic material in an individual’s cells. It is 
utilized in order to understand chromosomal abnormalities and other genomic mutations. 
2.2.2. Comparative Genomic Hybridization (CGH) and Array CGH (aCGH) 
Comparative Genomic Hybridization (CGH) is a molecular cytogenetic method, which was 
developed by Kallioniemi et al. This method is capable of detecting the relative DNA sequence copy 
number between genomes that makes it useful for identifying regions of gain or loss of DNA in 
tumors (Kallioniemi, Kallioniemi et al. 1992).    
Weinberg (2013) defines Comparative Genomic Hybridization (CGH) as a procedure in which the 
copy numbers of a large array of genomic sequences from cells of interest, for instance cancer cells, 
are compared with the copy numbers of the corresponding sequences in normal reference DNA. This 
determines whether the various sequences being analyzed are present in increased or decreased copy 
number in the cells of interest (Weinberg 2013).  
Speicher and Carter (2005) explain how CGH works. First, DNA from the test sample and a normal 
reference sample is extracted. Afterwards, the extracted test and normal samples are labelled 
differentially; for instance, with green and red color respectively. In the next step, the combined 
probes are applied to target metaphase chromosomes and compete for complementary hybridization 
sites. As a result, the amplified regions in the test sample are predominantly green while deleted 
regions in the test sample are red. Next, digital image analysis is used to quantify the ratios of test to 
reference fluorescence along the chromosomes. Increased fluorescence ratios denote gains and 
amplifications. On the other hand, reduced fluorescence ratios denote losses and deletions (Speicher, 
Carter 2005). 
CGH has some limitations. The main limitation of this method is its inability to detect mosaicism, 
balanced chromosomal translocations, inversions, and whole-genome ploidy changes. Furthermore, 
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the resolution of this method is limited and as a result aberrations smaller than 5-10 Mbp. cannot be 
detected (Oostlander, Meijer et al. 2004). Array Comparative Genomic hybridization (aCGH) is 
another method that overcomes the limited resolution of the conventional CGH and it has been mainly 
in use in cancer research.    
In aCGH, metaphase chromosomes are replaced by cloned DNA fragments of size 100-200 kbps that 
are spotted onto a glass slide (the array). Furthermore, the exact chromosomal location of each 
fragment is known which provides the possibility to map the aberrant changes directly onto the 
genomic sequence (Oostlander, Meijer et al. 2004). aCGH follows almost the same procedure as 
conventional CGH.  
In aCGH, the test and normal reference genomes are labelled differentially and hybridized to cloned 
fragments on the array. Next, with the help of image analysis the intensity differences in the 
hybridization patterns of both DNAs are calculated. The resulting intensity ratio reflects the copy 
number aberrations present in the genome (Oostlander, Meijer et al. 2004, Speicher, Carter 2005). 
In aCGH, the resolution of the analysis is restricted only by the size of the clones and by the distance 
between consecutive clones on the array. Furthermore, aCGH can be automated easily for high-
throughput applications. Using aCGH, a whole genome analysis can be performed in a single 
experiment; while using FISH, the same goal is achieved with thousands of independent FISH 
hybridization (Speicher, Carter 2005, Oostlander, Meijer et al. 2004). Another advantage of the aCGH 
over FISH is that it does not require targeting a gene of interest. Moreover, aCGH can detect CNA 
events involving genomic regions as large as whole chromosomes (Moore, Persons et al. 2008). The 
main limitation of aCGH is its inability to detect aberrations that do not result in copy number changes 
(Oostlander, Meijer et al. 2004). For instance, in a copy-neutral LOH event, the copy number does 
not change and this kind of aberration cannot be detected by the aCGH method. However, Single 
Nucleotide Polymorphism (SNP) arrays are able to overcome such limitation. A SNP is a variation 
that occurs at a single site in DNA.  
2.2.3. Single Nucleotide Polymorphism Arrays 
A single nucleotide polymorphism (SNP) is a variation at a single nucleotide position in a DNA 
sequence among individuals. SNP arrays are high-density arrays based on oligonucleotides that can 
identify both copy number alterations and LOH at individual nucleotides (Speicher, Carter 2005). 
One advantage of SNP arrays over aCGH is its ability to measure not only the total intensity at each 
probe but also the ratio of the intensities between two alleles (Chen, Chang et al. 2013).  
To infer a SNP genotype (AA, AB, BB), SNP arrays utilize the principle that each nucleotide base 
binds to its complementary counterpart (i.e. ‘A’ binds to ‘T’ and ‘C’ binds to ‘G’). In an SNP array 
experiment, single-stranded DNA fragments hybridize to probes with unique sequences. Each probe 
composed of k-mer oligonucleotides (where k depends on platform) is designed to bind to a specific 
target DNA fragment. After hybridization, a signal intensity is measured and assigned to each probe 
and its target depending on the amount of target DNA in the sample and the affinity between target 
DNA and probe. Finally, these signal intensities are extensively processed and analyzed to infer the 
SNP genotype (LaFramboise 2009).  
In addition, SNP arrays can be used to determine the copy number. The inference of copy number 
from the SNP array data is based on the observation that the expected probe intensity increases with 
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increased quantity of DNA harboring the region interrogated by the probe. Tools inferring the copy 
number from the SNP array data, first, summarize the probe-level intensity values at each SNP 
position and then compare this summary measure against summary measure obtained from a panel 
of normal samples. This results in the inference of raw copy number, which is a rough measure of the 
true underlying copy number. These raw copy numbers are subsequently smoothed and segmented to 
identify segments with CNA. Newer versions of SNP arrays have many thousands of copy number 
probes solely designed to interrogate copy number variation and as a result, there is no need for the 
summarization step in inferring the copy number (LaFramboise 2009).  
2.2.4. CNA Detection using High Throughput Sequencing Technologies 
High throughput sequencing technologies provide the ability to sequence whole genomes or targeted 
regions of interest rapidly and cheaply. They achieve this by sequencing in parallel massive amounts 
of short DNA fragments coming from the genome (Liu, Morrison et al. 2013). These technologies 
are gradually replacing the use of automated Sanger sequencing, which was the dominant method of 
sequencing for almost two decades.  
During the past several years, HTS-based approaches have become the primary means of detecting 
CNA. HTS-based approaches have several advantages compared with array-based CNA detection 
approaches. For instance, the estimation of integral copy number from HTS data is more accurate 
since there is a linear relationship between read-depth and copy number. Furthermore, the 
identification of the boundaries (breakpoints) of the segments with different copy numbers is more 
precise since the HTS data covers nearly all nucleotides in the genome. In addition, using HTS data, 
more alleles can be identified as opposed to the estimation of allele-specific copy number in array-
based methods, which is restricted to predefined alleles (Klambauer, Schwarzbauer et al. 2012).  
HTS-based CNA detection is performed based on either WGS, WES or targeted sequencing data. 
WGS is the process of sequencing of an organism’s entire genetic code. However, currently 
performing a WGS may cost up to a few thousands of euros. In contrast, WES is relatively cheaper 
since it only sequences the exome (i.e. all the exons or the coding portions of genes) in the genome. 
However, WES has its own limitations in detecting CNA. For instance, since WES only sequences 
the coding regions, a hypothetical CNA region extending into the adjacent non-coding region cannot 
be accurately detected since there is no data coming from the end that falls into the non-coding region. 
Alkan et al. (2011) enumerate four different main methods for detecting CNA from HTS data. These 
are (1) read-pair methods, (2) split-read methods, (3) sequence assembly methods, and (4) read-depth 
methods (Alkan, Coe et al. 2011).  
In the read-pair methods, the mapping information (i.e. span and orientation) of mapped paired-end 
reads are assessed in order to discover the reads that their span sizes and orientations deviate from 
what is expected. In principle, this method is capable of detecting most classes of structural variation. 
For instance, deletion can be detected from read-pairs that map too far apart each other. Some tools 
that use read-pair method are PEMer (Korbel, Abyzov et al. 2009), VariationHunter (Hormozdiari, 
Hajirasouliha et al. 2010) and BreakDancer (Chen, Wallis et al. 2009).  
Split-read methods utilize the splits in the sequence-reads in order to detect structural variation. If 
there is a continuous stretch of gaps in the aligned read, it indicates a deletion. If there is a continuous 
stretch of gaps in the reference where the read is aligned, it indicates an insertion. Even though split-
 12 
read methods are capable of detecting all classes of structural variation at the single-base pair 
resolution, they require longer reads. One example of a tool that uses split-read method is Pindel (Ye, 
Schulz et al. 2009).  
Sequence assembly methods are theoretically capable of detecting all classes of structural variation 
by performing de novo assembly if the reads are long and accurate. However, in practice, a 
combination of de novo assembly and local assembly is used to construct the genome from scratch. 
Once the genome is assembled, it can be contrasted against the reference genome to identify the 
structural variants. One example of a tool that performs de novo assembly and detection of structural 
variation is Cortex (Iqbal, Caccamo et al. 2012).  
Read-depth methods are only capable of detecting two classes of structural variation that are 
duplications and deletions by examining the increase and decrease in the depth of coverage 
respectively. Furthermore, read-depth methods are incapable of distinguishing tandem duplications 
from interspersed duplications (Alkan, Coe et al. 2011). However, read-depth methods can be 
augmented to identify copy-neutral LOH events by incorporating data about the fraction of alternate 
allele at heterozygous SNP positions in the method. Some tools that use read-depth method are 
ControlFREEC (Boeva, Popova et al. 2012b), CNAnorm (Gusnanto, Wood et al. 2012), CLImAT 
(Yu, Liu et al. 2014), and Patchwork (Mayrhofer, DiLorenzo et al. 2013). Since in this study the aim 
was to detect only duplications, deletions and copy-neutral LOH, the use of read-depth detection 
methods seemed appropriate. Because of this choice of method, out of the four detection methods, 
read-depth methods are explained in more details.  
In order to perform CNA detection based on read-depth methods the first step is to map or to align 
the millions of reads obtained from either WGS or WES to a reference genome. After the reads have 
been mapped to the reference genome, different read-depth methods use different approaches to 
perform the CNA detection. However, three main steps are common to many of these methods: (1) 
raw copy number inference, (2) segmentation and (3) copy number classification (Alkodsi, Louhimo 
et al. 2015).  
2.2.4.1. Raw Copy Number Inference 
In the first step, the read-depth (coverage) data is extracted from the aligned reads. Read-depth 
represents the number of reads that fall into or overlap a local genomic region in the reference 
genome. Once the read-depth data is available, the raw copy number for each local genomic region 
can be inferred by calculating the read-depth ratio between tumor and normal samples.  The basic 
assumption behind the use of read-depth in CNA detection is that the average read-depth of a genomic 
region is proportional to its copy number (Liu, Morrison et al. 2013). In principle, in a diploid 
genome, the read-depth ratio equal to 1 indicates that there has been no change in the copy number, 
one copy gain and one copy loss are represented by a ratio of 1.5 and 0.5 respectively 
(Sathirapongsasuti 2015). Sometimes these ratios are transformed into logratios by taking the 
logarithm of the calculated ratios. As a result, the expected read-depth logratio for a region with no 
copy number change is equal to 0. However, some sources of bias such as mapability and GC-content 
influence the number of reads aligned to a given region in the genome. Furthermore, normal cell 
contamination also affects the estimation of raw copy number (Alkodsi, Louhimo et al. 2015). Normal 
cell contamination refers to the fact that tumor biopsy samples are mixtures of normal and cancer 
cells. Oesper et al. (2013) define the tumor purity – a term closely related to normal cell contamination 
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- of a sample as “the fraction of cells in the sample that are cancerous, and not normal cells”. As a 
result, high normal cell contamination or low tumor purity decreases the power to detect copy number 
aberrations in the cancer genome by shifting the read-depth ratios and allele fraction values away 
from the expected values (Oesper, Mahmoody et al. 2013).    
Liu et al. (2013) define mapability as “the probability for a region in the reference genome that a read 
originating from it is unambiguously mapped back to it.” Mapability bias arises from the fact that 
some of the short reads originating from the identical or highly similar regions in the genome cannot 
be mapped uniquely to the reference genome. During the read alignment, these reads known as multi-
reads are either discarded or mapped to a random position out of all equally good match positions. 
As a results, regions in the genome with low mapability show lower mapped read-depth.  
GC-content bias arises because the read-depth of the regions in the genome with high or low GC-
content is lower than regions with medium GC-content. It is believed that the GC-content bias is 
caused mainly by the polymerase chain reaction (PCR) amplification step (Liu, Morrison et al. 2013, 
Alkodsi, Louhimo et al. 2015).   
In order to correct for such biases different tools uses different approaches. Tools that require a 
matched normal sample assume that these biases largely and implicitly are corrected for when the 
read-depth ratio of the tumor and normal sample is being calculated. Other tools that do not require 
a matched normal sample, for instance ControlFREEC, perform mapability bias correction and CG-
content normalization. 
Even though read-depth methods can detect CNAs solely using read-depth ratios, another source of 
information, B-allele fraction (BAF), can improve the CNA detection results. The human genome is 
diploid and so normally has two copies of its autosomal chromosomes. A locus in the normal human 
genome can have one of four possible genotypes (AA, AB, BA, and BB). Let ‘A’ represent the allele 
that has the same nucleotide as the reference genome (the reference allele) and ‘B’ represent the 
alternate allele. BAF is the estimation of allelic fraction at a SNP locus and it is calculated as: 
𝐵𝐴𝐹 =  
𝑏
(𝑎 + 𝑏)
 
where 𝑎 and 𝑏 are the copy numbers of A and B allele respectively (Liu, Morrison et al. 2013). Using 
this formula, the BAFs for the four possible genotypes, AA, AB, BA and BB are 0, 0.5, 0.5 and 1 
respectively. In a normal genome, at heterozygous SNP loci BAF values are equal to 0.5. A CNA 
event can shift these values away from 0.5. Thus, BAF values at heterozygous SNP loci are 
informative in a sense that any deviation from 0.5 may point to a CNA event. For instance, the use of 
BAF can aid in the identification of copy-neutral LOH events normally not detectable solely by the 
use of read-depth ratios. A copy-neutral LOH happens when in a given region of a diploid genome, 
one copy of the genome is deleted and the other copy is doubled. Alternatively, in a given region of 
a diploid genome, one copy of the genome can be doubled and later the other copy is lost. Another 
mechanism through which copy-neutral LOH can occur is gene conversion also known as acquired 
uniparental disomy (aUPD). Gene conversion is a process through which genetic material from an 
intact region of genome is transferred to a region containing double-strand breaks. Gene conversion 
can occur between sister chromatids, homologous chromosomes, and even between homologous 
sequences on the same chromatid or on different chromosomes (Chen, Cooper et al. 2007). As a 
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result, the DNA sequences become homozygous after the gene conversion event. Even though a CNA 
event has happened, the read-depth ratio remains equal to one suggesting that no event has happened 
but BAF values for heterozygous SNP loci is no longer equal to 0.5 pointing to the occurrence of a 
CNA event. It is important to note that, BAF values at heterozygous loci cannot detect all of the CNA 
events by themselves. For instance, there might be a CNA event where both copies of the 
chromosome are doubled; the genotype at the heterozygous SNP loci is AABB, however, the BAF 
value remains equal to 0.5. Thus, a combination of read-depth ratios and BAF can improve CNA 
detection results.  
2.2.4.2. Segmentation 
The second step is to segment the inferred raw copy numbers. Segmentation refers to a process where 
a chromosome is divided into segments of similar copy number based on the inferred raw copy 
numbers. In order to create the segments, change-points in the raw copy number should be identified. 
There are different methods developed to perform the segmentation. For instance, in circular binary 
segmentation (CBS), the method finds the segments in a chromosome with the criteria of minimizing 
the within-segment variance and maximizing the between-segments variance (Olshen, Venkatraman 
et al. 2004, Liu, Morrison et al. 2013). CBS was originally developed for aCGH data. To find a 
change-point, CBS uses a likelihood ratio test statistic to test whether a segment can be divided into 
two segments having different means. Conceptually, a segment is spliced at the two ends to form a 
circle. Then, the likelihood ratio test statistic for testing the hypothesis that the arc from 𝑖 +  1 to 𝑗 
and its complement have different means is given by: 
  
𝑍𝑖𝑗  =  {1/(𝑗 −  𝑖)  +  1/(𝑛 −  𝑗 +  𝑖)}
−1/2{(𝑆𝑗  −  𝑆𝑖 )/( 𝑗 −  𝑖 )  −  (𝑆𝑛  −  𝑆𝑗  +  𝑆𝑖 )/(𝑛 −  𝑗 +  𝑖 )}. 
 
where 𝑆𝑖  and 𝑆𝑗  are the partial sums of the logratios of intensities (i.e. 𝑋1, … , 𝑋𝑛) indexed by the 
location of the 𝑛 markers being studied in aCGH data (i.e. 𝑆𝑖  =  𝑋1  + ···  + 𝑋𝑖 , 1 ≤  𝑖 ≤  𝑛  and 𝑆𝑗  =
 𝑋1  + ···  + 𝑋𝑗 , 1 ≤  𝑗 ≤  𝑛 ). In addition, the statistic 𝑍𝐶  =  𝑚𝑎𝑥1≤𝑖<𝑗≤𝑛 |𝑍𝑖𝑗| is calculated. A change 
is called if this statistic exceeds a threshold level based on the null distribution of 𝑍𝐶  computed using 
Monte Carlo simulation or approximation. After the rejection of the null hypothesis (i.e. there is no 
change in mean in a segment), the change-point(s) is (are) estimated to be 𝑖 (and 𝑗) such that 𝑍𝐶 =
|𝑍𝑖𝑗|. Finally, this procedure is applied recursively to identify all the changes (Olshen, Venkatraman 
et al. 2004). CBS has been shown to be one of the most accurate approaches in the detection of CNAs. 
However, this approach is slow and requires 𝑂(𝑛2) computations. In contrast, hidden Markov model 
(HMM), other way to perform segmentation, only requires 𝑂(𝑛) computations (Crisan, Xiang 2009). 
 
HMMs are probabilistic models designed to determine a hidden (i.e. unknown) sequence of states 
based on a sequence of observations (Seiser, Innocenti 2015). A change from one state to another 
state (where the new state of a sequence is only dependent on its previous state) is described by a 
matrix of transition probabilities. The transition probabilities describe the expected linear order of 
states (Eddy 2004). Furthermore, each step has an emission probability. Emission probabilities model 
each of the observations as a function of a particular hidden state. To identify the most likely hidden 
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sequence based on the model, HMMs first optimize model parameters (including the emission and 
transition probabilities) to best describe the sequence of observations by learning from training data. 
After parameter optimization, HMMs determine the most likely sequence of hidden states using a 
dynamic programming approach (Seiser, Innocenti 2015).  
 
In HMM-based CNA detection method, the observed read-depth ratios and the BAF values represent 
residues emitted from the hidden copy number state at each locus. Each possible copy number state 
has specific emission probabilities that model the read-depth ratio and BAF value composition for 
that state. In addition, copy number states are dependent on adjacent loci. The transition probabilities 
describe the probabilities associated with either remaining in the current copy number state or 
transitioning to a new copy number state at the next locus. The emission and transition probabilities 
and other parameters are optimized based on the observed sequence of read-depth ratios and BAF 
values and subsequently the optimized parameters are used to determine the most likely sequence of 
hidden copy number states. Once the copy number state at each locus is determined, loci with the 
same state are combined to create a segment (Seiser, Innocenti 2015, Liu, Morrison et al. 2013). 
 
In order to perform the segmentation, some tools use the methods explained above. For instance, 
Patchwork uses CBS and CLImAT develops its own HMM. However, some tools employ different 
approaches than described above. For instance, ControlFREEC has developed its own segmentation 
method by using least absolute shrinkage estimator (LASSO) regression (Alkodsi, Louhimo et al. 
2015, Liu, Morrison et al. 2013, Boeva, Popova et al. 2012). 
   
2.2.4.3. Copy Number Classification 
The third step is to classify and annotate different segments into different copy number states. Some 
tools assign an integral copy number to each segment and some other tools only calculate and report 
the copy number ratio for each segment by finding either the mean or the median copy number of the 
segment. For instance, ControlFREEC assigns an integral copy number to each segment. 
Furthermore, it annotates the segments as gain or loss. If the analysis is done using a paired normal 
sample, ControlFREEC annotates the copy number variation segments either as somatic or germline. 
Tools using HMM normally combine steps two and three because in step two the state (integral copy 
number) is already inferred. 
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3. Research Objectives 
The main objective of this research is to develop a tool capable of detecting copy number alterations 
and copy-neutral LOH events in tumor genomes. The tool should be able to detect accurately genomic 
aberrations such as deletion, amplification and copy-neutral LOH events and distinguish regions in 
the cancer genome that have acquired such aberrations from normal regions by annotating them 
accordingly. Furthermore, the tool should be easy-to-use and fast in performing the analysis.   
The main objective can be broken into the following steps: 
1. Developing and implementing an algorithm for copy number analysis 
2. Implementing a simulator capable of simulating read-depth and BAF data 
3. Benchmarking the algorithm with simulated and real data 
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4. Material and Methods 
This chapter explains the implementation of the tool and the materials and methods that were used in 
order to implement it. Furthermore, in this chapter, the implementation of a simulator capable of 
simulating the cancer genome with events such as deletion, amplification and copy-neutral LOH is 
explained. 
4.1. Mapping the Reads 
HTS technologies produce millions of ‘reads’ that are the result of sequencing of the fragmented 
DNA. These reads need to be ‘mapped’ or ‘aligned’ to the reference genome by determining their 
position on the reference genome (Trapnell, Salzberg 2009). Aligning the reads to a reference genome 
is the first step in many high throughput sequencing data analyses. Since there are millions of reads 
to be aligned to the reference genome, one of the important challenges is the speed of the alignment. 
The other challenge is the accuracy of the alignment. There are several tools available capable of 
performing the mapping of the reads such as Bowtie (Langmead, Trapnell et al. 2009), BWA (Li, 
Durbin 2009), MAQ (Li, Ruan et al. 2008), etc. Each of these tools employs different strategies. For 
instance, Bowtie uses Burrows-Wheeler transform to transform and index the reference genome. The 
result of the transformation is then stored in the computer’s memory. Then, Bowtie aligns a read one 
character at a time to the Burrows-Wheeler-transformed genome up until the whole read is aligned. 
Bowtie also utilizes a backtracking algorithm that permits mismatches (Trapnell, Salzberg 2009, 
Langmead, Trapnell et al. 2009).    
4.2. SAM/BAM File Format 
The sequence alignment/map (SAM) format is a widely used and generic alignment format for the 
storage of the aligned reads against the reference sequences. SAM format is capable of supporting 
short and long reads produced by different sequencing platforms (Li, Handsaker et al. 2009). 
The SAM format is comprised of two sections and several tab-delimited fields. The two sections are 
the header and the alignment section. The alignment section is comprised of several lines and each 
line has 11 mandatory and some other optional fields (Li, Handsaker et al. 2009). Table 4.1 describes 
each of the mandatory fields in the SAM format. 
  
Table 4.1 Mandatory fields in SAM format (adapted from Li, Handsaker et al. 2009). 
No. Name Description 
1 QNAME Query NAME of the read or the read pair 
2 FLAG Bitwise FLAG (pairing, strand, mate strand, etc.) 
3 RNAME Reference sequence NAME 
4 POS 1-Based leftmost POSition of clipped alignment 
5 MAPQ MAPping Quality (Phred-scaled) 
6 CIGAR Extended CIGAR string (operations: MIDNSHP) 
7 MRNM Mate Reference NaMe (‘=’ if same as RNAME) 
8 MPOS 1-Based leftmost Mate POSition 
9 ISIZE Inferred Insert SIZE 
10 SEQ Query SEQuence on the same strand as the reference 
11 QUAL Query QUALity (ASCII-33=Phred base quality) 
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The binary alignment/map (BAM) is the binary, compressed representation of SAM that makes it 
smaller in size. In addition, retrieval of the alignments that overlap a given chromosomal region is 
faster by performing linear indexing on a position-sorted BAM file. This capability relaxes the need 
to load the entire file into memory and furthermore, provides the ability of stream-based processing 
on a specific genomic region (Li, Handsaker et al. 2009).  
4.3. Samtools  
Samtools is a software package capable of parsing and manipulating alignments in the SAM/BAM 
format. Samtools provides its users with several abilities such as (1) Sorting, indexing and merging 
the alignments, (2) Removing PCR duplicates, (3) Generating per-position information in pileup 
format, (4) Calling SNPs and short indel variants, and (5) Representing alignments in a text-based 
viewer (Li, Handsaker et al. 2009). 
4.4. Wiggle File Format 
The wiggle (WIG) format is used for display of dense, continuous data such as GC percent, 
probability scores, and transcriptome data. This format is composed of one wiggle-track definition 
line and two other types of lines: declaration lines and data lines. Furthermore, Wiggle format 
provides two formatting options: fixedStep and variableStep.  
FixedStep formatting is used for data with regular intervals between new data values. This format is 
best used for genome-wide datasets containing millions of data points. The declaration line starts with 
the word fixedStep and includes specifications for chromosome (chrom parameter), start coordinate 
(start parameter), and step size (step parameter). This line harbors one optional parameter, the span 
parameter with default value equal to 1. The span parameter declares the number of bases that each 
data value should cover and allows data composed of contiguous runs of bases with the same data 
value to be specified more succinctly.   
VariableStep formatting is used for data with irregular intervals between new data values. This 
format, like fixedStep, is best used for genome-wide data set comprising of millions of data points. 
The declaration line starts with the word variableStep and is followed by a specification for a 
chromosome (chrom parameter) and the optional span parameter having the same meaning as 
explained earlier (genome.ucsc.edu 2015, genomewiki.ucsc.edu 2015, ensembl.org 2015). 
In this work, the read-depth data is stored in files with WIG format. 
4.5. SEG File Format 
SEG file (segmented data) is a tab-delimited text file that lists loci and their associated numeric 
values. The first row contains column headings and each subsequent row contains a locus and an 
associated numeric value (broadinstitute.org 2015). A typical SEG file has at least 5 columns which 
are: ID, chrom (indicating the chromosome), loc.start (indicating the start location of the locus), 
loc.end (indicating the end location of the locus) and finally one or more columns assigning a numeric 
value to the specified locus.  
This format is used by visualization tools such as the Integrative Genomics Viewer (IGV) for the 
visualization of the results stored in a file with the SEG format. IGV reads the first four columns as 
track name, chromosome, start location, and end location. If there are more than 5 columns in the 
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SEG file, IGV reads the last column as the numeric value for that locus while ignoring all other 
columns (broadinstitute.org 2015). 
In this work, the developed tool outputs the results of copy number analysis and segmentation in the 
SEG file format. This provides the capability of visualizing the results in tools such as IGV.     
4.6. Integrative Genomic Viewer (IGV) 
The Integrative Genomics Viewer (IGV) is a high-performance and lightweight visualization tool for 
interactive exploration of large, integrated genomic datasets. It supports a wide variety of data types, 
including array-based data, next-generation sequencing data, and genomic annotations such as 
aligned sequence reads, mutations, copy number, RNA interference screens, gene expression, 
methylation and genomic annotations (Robinson, Thorvaldsdóttir et al. 2011).  
One advantage of using IGV over other available genome browsers such as MapView, EagleView, 
etc. is that it supports visualizing and viewing of different supported data types together and to use 
the sample metadata to group, sort and filter them (Robinson, Thorvaldsdóttir et al. 2011).  
IGV provides its users with the ability to zoom in, zoom out and pan across the genome from the 
whole genome to a single base pair. These, along with other capabilities such as for instance sorting 
the reads in a BAM file by base, quality or strand, or as for another example the color coding of 
paired-end reads provides its users with the ability to visually inspect the data and performing further 
validations (Robinson, Thorvaldsdóttir et al. 2011). 
Since IGV supports all file formats used in this work, and the fact that it is freely available and easy-
to-use, it was chosen as the genome browser of choice.   
4.7. Python Programming Language 
Python is a free, portable and general-purpose high-level programming language. In recent years, the 
popularity of Python programming language has increased among bioinformaticians. In this work, 
Python programming language was used as the implementation language for our software.   
4.8. The Cancer Genome Atlas (TCGA)  
The Cancer Genome Atlas (TCGA) is a comprehensive and coordinated effort started in 2006 as a 
three-year pilot project and continued afterwards in order to accelerate the understanding of the 
molecular basis of cancer through the application of genome analysis technologies, including large-
scale genome sequencing (The Cancer Genome Atlas 2015).  
The main goal of TCGA is to improve the ability to diagnose, treat and prevent cancer by providing 
an atlas of genomic changes caused by each type of cancer. TCGA has collected more than 30 tumor 
types. For each tumor type, TCGA has collected and examining up to 500 samples in order to provide 
the statistical power needed to produce a comprehensive genomic profile of each cancer type.   
Furthermore, TCGA provides an infrastructure for making cancer-related data publicly available to 
the researchers all around the globe. It is believed that this would enable the cancer research 
community to make and validate important discoveries (The Cancer Genome Atlas 2015). The 
collected cancer-related data is available for download at either TCGA’s Data Portal (Tcga-
data.nci.nih.gov 2015) or at Cancer Genomics Hub (CGHub) (cghub.ucsc.edu 2015). TCGA’s Data 
Portal hosts clinical information, genomic characterization data, and high-level sequence analysis of 
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the tumor genomes. On the other hand, lower levels of sequence data such as alignments stored in 
BAM files are available at CGHub.   
4.9. Data 
In this work, the BAM files storing the alignments of a WGS data for paired normal and tumor 
samples of 6 individuals diagnosed with prostate adenocarcinoma (PRAD) was selected and 
downloaded from the CGHub in order to run the copy number analysis tool developed in this thesis 
over the downloaded data. Furthermore, other available copy number analysis tools were run over 
the same data in order to benchmark the performance of the developed tool in this work. Table 4.2 
represents the filter used to search for the eligible samples in CGHub.  
4.10. Input Files 
The tool requires three input files. The first two files contain the read-depths for the normal and tumor 
samples. These files have a wiggle (WIG) format. The third file, which is a tab-separated file with 
TSV format, contains the BAF values at heterozygous SNPs. These files are obtained by running the 
tools available in the pypette package over the BAM files. Pypette is a set of utilities for the analysis 
of high throughput sequencing data available at: https://github.com/annalam/pypette (Appendix C 
represents the set of commands used to extract the read-depth and BAF data from the BAM files). 
4.10.1. Extraction of Read-depth and Heterozygous B-Allele Fraction Data 
Figure 4.1 illustrates how the read-depth (coverage) is calculated from the BAM files. A window of 
specific size is slid over the mapped reads and the number of reads which fall within the window or 
have an overlap with the window determines the read-depth at the window. 
  
Table 4.2 Filters used for searching for samples in the CGHub. 
Disease: Prostate adenocarcinoma (PRAD) 
Study: TCGA 
Platform: Illumina 
Library Type: WGS 
 
 
Figure 4.1 Calculation of read-depth (coverage) from a BAM file. 
 21 
The B-allele fraction is defined as the number of alternate alleles (B-allele) at a specific position in 
the genome divided by the total number of aligned reads at that position: 
 
B_allele Fraction =  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑎𝑙𝑡𝑒𝑟𝑛𝑎𝑡𝑒 𝑎𝑙𝑙𝑒𝑙𝑒𝑠
𝑇𝑜𝑡𝑎𝑙 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑟𝑒𝑎𝑑𝑠
 
 
The B-allele fraction at heterozygous SNPs is 0.5 since half of the reads come from the reference 
allele and the other half from the alternate allele.    
4.11. Pipeline of the Tool 
Figure 4.2 illustrates the pipeline of the tool. First, the read-depths from the normal and tumor sample 
are used to calculate the read-depth logratios. Furthermore, the B-allele fraction data is smoothed. 
Then, the read-depth logratios and the smoothed BAF are used for segmenting the genome by using 
a double sliding window method. Finally, the tool outputs the result of segmentation as a SEG file. 
In addition, another tool was developed to extract copy-neutral LOH events from the output of the 
developed tool. In what follows, each of these steps is explained in detail.  
4.11.1. Calculation of the Logratios 
Figure 4.3 illustrates how the read-depth logratios are calculated. Furthermore, this figure illustrates 
the visualization of the normal and tumor samples coverages and the resulting read-depth logratios in 
IGV. It should be mentioned that in the calculation of the read-depth logratios, regions with read-
depth below a certain point are discarded (i.e. their value is replaced by not a number (NAN) value) 
since they are believed to be non-informative. This threshold is given to the tool as an argument –
min_read. By default, min_read is set to be minimum of 50 reads. 
 
Figure 4.2 Pipeline of the tool. 
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Figure 4.3 Calculation of the read-depth (coverage) logratio and its visualization in IGV. 
 
As it can be seen from figure 4.3, read-depth logratios can specify the regions that are harboring 
aberrations. If a region in genome is not aberrant, the read-depth ratio of tumor read-depth to normal 
read-depth is close to one and therefore, the logarithm of this ratio is close to zero. However, if a 
region has undergone amplification, the read-depth ratio of tumor read-depth to normal read-depth is 
greater than one and as a result, the logarithm of this ratio is greater than 1. In addition, if a region 
has undergone deletion, the read-depth ratio of tumor read-depth to normal read-depth is less than 
one and resulting in a negative log ratio. However, if a region in genome has undergone a copy-
neutral LOH, it cannot be detected via the read-depth logratio since the read-depth logratio for this 
region is close to zero. The B-allele fraction is used to identify such aberrations in the genome. 
4.11.2. Correction for GC-content and Mapability Bias  
As explained earlier biases such as mapability and GC-content complicate the inference of the raw 
copy number. Low mapability regions in the genome show lower mapped read-depth and the read-
depth of the regions in the genome with high or low GC-content is lower than regions with medium 
GC-content. This requires the need to correct for such biases. In this work, it is assumed that these 
biases are largely and implicitly corrected for when the read-depth ratio of the tumor and normal 
sample is being calculated because of using a matched normal sample. The idea behind this 
assumption is that these biases affect both the normal and the tumor samples in a similar way 
(Klambauer, Schwarzbauer et al. 2012).   
4.11.3. Mirroring and Smoothing of B-allele Fractions 
As explained earlier, the read-depth logratios are not alone capable of detecting the copy-neutral LOH 
events and the use of BAF values at the heterozygous SNPs helps in the identification of such 
aberrations. The expected value for BAF at a heterozygous SNP in a diploid organism is equal to 0.5 
 23 
since half of the reads are the reference allele and the other half are the alternate allele. Figure 4.4 
illustrates how the BAF values at heterozygous SNPs shift away from the expected value of 0.5 at 
regions with different aberrations.  
As it can be seen from the BAF track in figure 4.4, BAF values are symmetrically positioned around 
0.5. In order to make the analysis of BAF data easier, the BAF values are mirrored or flipped around 
the 0.5 axis. This process is known as mirroring. As a result, the flipped BAF value for a SNP at a 
normal region in a diploid organism is equal to 0. The flipped BAF track in figure 4.4 illustrates the 
result of mirroring. Simultaneous with mirroring, through a process known as smoothing, the noise 
in the BAF data is reduced by applying a median filter to it. The median filter filters the data by 
running through the data points one by one and replacing each of the data points with the median of 
the data points that fall into a window of specified size centered on the current data point. To perform 
the simultaneous mirroring and smoothing, first two different ways of smoothing and mirroring are 
considered depending on whether a BAF value is close to 0.5 or it is close to either 0 or 1. If the BAF 
value is close to 0.5, the best way of simultaneous mirroring and smoothing is to calculate: 
 
|0.5 − 𝑚𝑒𝑑𝑖𝑎𝑛(𝑥)|. 
 
However, if the BAF value is close to either 0 or 1, the best way of simultaneous mirroring and 
smoothing is to calculate: 
𝑚𝑒𝑑𝑖𝑎𝑛(|0.5 − 𝑥|). 
 
To find out how close a BAF value is to 0.5 (i.e. a heterozygous SNP has a BAF value equal to 0.5) 
the heterozygosity measure is calculated in the following way: 
 
ℎ𝑒𝑡𝑒𝑟𝑜𝑧𝑦𝑔𝑜𝑠𝑖𝑡𝑦 = 𝐻 = 1 − 2 ∗ |0.5 − 𝑥|. 
 
where 𝑥 represents a BAF value. If a BAF value is close to 0.5, the heterozygozity value is close to 
1 and if a BAF value is close to either 0 or 1, the heterozygozity value is close to 0. Using the 
following linear interpolation formula, BAF values are simultaneously mirrored and smoothed: 
 
𝐻 ∗ |0.5 − 𝑚𝑒𝑑𝑖𝑎𝑛(𝑥)| + (1 − 𝐻) ∗ 𝑚𝑒𝑑𝑖𝑎𝑛(|0.5 − 𝑥|). 
 
where 𝐻 is the heterozygosity measure and 𝑥 is a BAF value. Figures 4.5 to 4.7 illustrate the read-
depth logratio and the BAF profiles before mirroring at regions with different events such as 
hemizygous deletion, homozygous deletion and copy-neutral LOH.      
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Figure 4.4 Illustration of BAF and flipped BAF values at regions with different aberrations. 
 
 
Figure 4.5 Illustration of a hemizygous deletion event. 
 
Figure 4.6 Illustration of a homozygous deletion event. 
 
Figure 4.7 Illustration of a copy-neutral LOH event. 
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4.12. Double Sliding Window Method 
After the calculation of the read-depth logratios and calculation of smoothed BAF values, the data is 
ready for segmentation. In order to segment the genome based on events such as deletion or 
duplication a double sliding window method was used. Here, first, the method is explained in case of 
segmenting the genome based on only the read-depth logratios values and then, the strategy for the 
segmentation of the genome based on both read-depth logratios and BAF values will be explained.  
Two windows of the same size where the end of the first window touches the beginning of the second 
window is slid over read-depth logratio values and the mean of these values for each of the windows 
is calculated. Then the absolute mean difference for logratios for the two consecutive windows is 
calculated. If the absolute mean difference of the logratios is above a certain threshold then the 
algorithm places a breakpoint at the position where the two windows touch each other. The breakpoint 
has a value that corresponds to the absolute mean difference of the logratios within the windows. 
Since both windows are slid over the logratio values one step at a time, we will end up with a cluster 
of breakpoints with different values. The next step is to choose the breakpoint with the maximum 
value and to discard the remaining breakpoints in the cluster. Figure 4.8 illustrates the idea of double 
sliding window for the logratio data. Figure 4.8 also illustrates the cluster of breakpoints at a specific 
locus of the genome where the breakpoint with the maximum value is highlighted in red. If for the 
placement of a breakpoint, a decision is made solely based on a read-depth logratio threshold, the 
decision boundary is determined only by one value. Figure 4.9 illustrates the decision boundary based 
on one value. 
 
Figure 4.8 Illustration of the double sliding window method functioning. 
 
Figure 4.9 Decision boundary based on one value. 
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Figure 4.10 Decision boundary based on two values. 
However, the developed tool uses two thresholds (i.e. read-depth logratio threshold and the BAF 
threshold) in order to decide whether a breakpoint should be placed at the position in the genome 
where two consecutive windows touch each other. To do this, first a compound score is calculated 
for each position in the genome using the absolute mean difference of the read-depth logratio values 
and the absolute mean difference of the BAF values. If the compound score is greater than 1, then a 
breakpoint is placed where the two windows touch each other. The following formula defines how 
the compound score is calculated. 
 
𝑐𝑜𝑚𝑝𝑢𝑛𝑑 𝑠𝑐𝑜𝑟𝑒 =
𝑎𝑏𝑠(𝑚𝑒𝑎𝑛(𝑙𝑜𝑔𝑟𝑤𝑖𝑛_1) − 𝑚𝑒𝑎𝑛(𝑙𝑜𝑔𝑟𝑤𝑖𝑛_2))
𝑙𝑜𝑔𝑟𝑎𝑡𝑖𝑜 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑
2
+
𝑎𝑏𝑠(𝑚𝑒𝑎𝑛(𝐵𝐴𝐹𝑤𝑖𝑛_1) − 𝑚𝑒𝑎𝑛(𝐵𝐴𝐹𝑤𝑖𝑛_2))
𝐵𝐴𝐹 𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑
2
 
 
Where 𝐵𝐴𝐹𝑤𝑖𝑛_𝑖  represents the BAF values in the 𝑖
𝑡ℎ  window and 𝑙𝑜𝑔𝑟𝑤𝑖𝑛_𝑖  represents the read-
depth logratio values in the 𝑖𝑡ℎ window.  
In this case, two values determine the decision boundary. Figure 4.10 illustrates the decision boundary 
based on these two thresholds.  
4.13. Multiple Window Sizes and Thresholds and Determination of Consensus Breakpoints 
It is possible some breakpoints will not be detected with only one window of a specific size. Thus, 
the tool uses multiple windows with different sizes and different thresholds. The size of each new 
window is 1.5 times larger than the previous one. The read-depth logratio threshold and BAF 
threshold are calculated for each of the new windows based the previous thresholds and a standard 
score in the following way. The calculated mean of the read-depth logratios within a window has a 
probability distribution. Assuming that the observed read-depth logratios within a window of size n 
are observations of a random sample from a normal (i.e.  𝑁(𝜇, 𝜎2)) population, the probability 
distribution of the mean is also normal (i.e. 𝑁(𝜇, 𝜎
2
𝑛⁄ ) ). This is based on the theorem stating that 
the linear combination of mutually independent normal random variables follows the normal 
distribution (Flury 1997). Increasing the window size, increases the sample size and consequently 
decreases the variance of the probability distribution of the mean. As a result, it can be determined 
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how much the standard deviation of the mean decreases when the window size becomes 1.5 times 
larger than the previous window size (i.e. 𝜎𝑛𝑒𝑤_𝑤𝑖𝑛 =  
1
√3 2⁄
2
∗ 𝜎𝑜𝑙𝑑_𝑤𝑖𝑛). The decrease in the standard 
deviation decreases the threshold used to call whether a change in the mean has occurred. The 
threshold specifies how many standard deviations away from the mean should be considered as a 
change. Therefore, the threshold can be thought of as the standard score (or z-score) multiplied by 
standard deviation:  
𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑 = 𝑧𝑠𝑐𝑜𝑟𝑒 ∗  𝜎. 
 
where 𝑧_𝑠𝑐𝑜𝑟𝑒  is the standard score and  𝜎  is the standard deviation. Having calculated the new 
standard deviation for the larger window, the new threshold can also be calculated as follows: 
 
𝑡ℎ𝑟𝑒𝑠ℎ𝑜𝑙𝑑𝑛𝑒𝑤_𝑤𝑖𝑛 = 𝑧𝑠𝑐𝑜𝑟𝑒 ∗  𝜎𝑛𝑒𝑤𝑤𝑖𝑛 =  𝑧𝑠𝑐𝑜𝑟𝑒 ∗  
1
√3 2⁄
2
∗ 𝜎𝑜𝑙𝑑𝑤𝑖𝑛 .    
 
After finding the breakpoints for each of the windows, all the breakpoints detected by the smallest 
window are accepted to be the consensus breakpoints. Then, breakpoints detected by the second 
window that is bigger than the first window and smaller than the remaining windows are added to the 
list of consensus breakpoints. However, for each of the breakpoints detected by the second window 
it is checked whether an already detected breakpoint falls inside the vicinity of this breakpoint. The 
vicinity is defined as one current window size before and one after the breakpoint. If there is already 
a breakpoint in the vicinity of the current breakpoint, the breakpoint is discarded and if not, the 
breakpoint is added to the list of consensus breakpoints. This procedure is continued until all the 
detected breakpoints by all the windows are checked. Figure 4.11 illustrates how consensus is found 
for two different windows. 
 
 
Figure 4.11 Determination of consensus breakpoints. 
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4.14. Segmentation and Merging the Segments 
Once the consensus breakpoints are identified, the segmentation is performed. Two consecutive 
breakpoints constitute a segment. For each segment, the average read-depth logratio and average BAF 
is calculated. However, if the absolute difference of the average logratios of two consecutive 
segments is below certain read-depth logratio merging threshold and the absolute difference of the 
average BAF of two consecutive segments is below a certain BAF merging threshold, these two 
consecutive segments are merged into one segment. Subsequently, the new average logratio and 
average BAF for the new segment are calculated. The results are written into a SEG file so that it can 
be visualized in IGV. The SEG file contains the following fields: Sample ID, chromosome, segment 
start point, segment endpoint, segment coverage logratio mean and segment BAF mean. Figure 4.12 
illustrates how the segmentation and merging works. 
4.15. Extraction of Copy-neutral LOH Events from SEG Files 
As explained earlier the resulting SEG file contains several fields. However, IGV is not capable of 
visualizing the results if the SEG file contains both the segment read-depth logratio mean and segment 
BAF mean. Thus, in order to be able to visualize the results in IGV, BAF mean field should be 
excluded from the SEG file and the visualization is done solely based on the read-depth logratio. This 
results in a situation where the segments with the copy-neutral LOH events are represented as normal 
and this regions cannot be detected by eye solely by looking at the visualized results in IGV. 
Therefore, a piece of code was written in order to extract copy-neutral LOH segments from the 
original SEG file. To do this, each segment in the SEG file is checked against two thresholds. If the 
read-depth logratio mean of each segment is below 0.1 and the BAF mean of the same segment is 
above 0.35, then the segment is considered to harbor a copy-neutral LOH event. 
 
 
Figure 4.12 Segmentation and merging of consensus breakpoints. (A) Consensus breakpoints (B) Segmentation based on 
breakpoints. (C) SEG 4 and SEG 5 from panel B are merged to make a new segment. 
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Figure 4.13 Extraction and report of regions with recurrent copy-neutral LOH across multiple samples. 
 
4.16. Extraction of Regions with Recurrent Copy-neutral LOH across Multiple Samples 
Regions with copy-neutral LOH may harbor genes with driver mutations (Barresi, Romano et al. 
2010). Thus detecting regions with recurrent copy-neutral LOH across multiple samples may be a 
good starting point for the detection of genes with driver mutation. Therefore, a small tool was 
developed to find these regions. The tool reports regions in the genome with copy-neutral LOH event 
and frequency of occurrence in that region across multiple samples. The results are reported 
chromosome-wise and sorted descending based on frequency of occurrence. Figure 4.13 illustrates 
how the regions with recurrent copy-neutral LOH are identified and reported. 
4.17. Simulator 
In order to evaluate the algorithm, a simulator capable of simulating the read-depth for both normal 
and tumor samples and BAF based on events such as deletion, amplification and copy-neutral LOH 
was developed. Simulator takes as input a normal sample read-depth data. The normal sample read-
depth data harbors noise and spatial correlation. By spatial correlation, it is meant that the values of 
the read-depths of two adjacent positions in the genome are correlated. As a result, the read-depth 
values of two adjacent positions tend to be close together and normally it is not expected to observe 
two adjacent positions in the genome having a huge difference in the read-depth. Figure 4.14 
illustrates the idea of spatial correlation. If the read-depth values in a read-depth file are iterated over, 
each x on the X-axis represents the read-depth value seen at the current position of the read-depth 
file. In addition, each y on the Y-axis represents the read-depth value seen at the next position in the 
read-depth file. Each point (x, y) on the XY plane is associated with a value z on the Z-axis. This 
value denotes how many times a specific (x, y) combination has occurred in the read-depth file. For 
instance, (400, 100, 0) denotes that no instances has been observed where the read-depth jumps from 
400 at the current position to the read-depth of 100 at the next position. As another example, (250, 
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254, 115) denotes that 115 times a change of read-depth from 250 reads at the current position to 254 
reads at the next position has been occurred. As it can be seen from figure 4.14, the values are 
clustered near 0 and near 250.             
The simulator, first, learns a model that takes into account the spatial correlation of adjacent positions 
and the noise present in the normal sample read-depth data. The model is used to simulate the read-
depth for each position in the genome harboring both noise and spatial correlation. Next, the noise is 
removed using a median filter. The result is the simulated read-depth with only spatial correlation of 
adjacent positions taken into account. This result is used to construct the normal and tumor read-
depths.  
The normal read-depth is constructed by adding independent Poisson noise to the simulated read-
depth at each position of the genome. To construct the tumor read-depth, first, two copy number 
tracks are constructed since chromosomes come in pairs (one for the maternal and one for the 
paternal). These two copy number tracks together represent the copy number status at each position 
of the genome. In the beginning these tracks represent a normal copy number (normal copy number 
= 2). Then, several regions are randomly constructed where their copy numbers deviate from normal. 
These regions represent events such as deletion, amplification and copy-neutral LOH. These regions 
are incorporated in the copy number track at random positions. Using both copy number track and 
the simulated read-depth, the read-depth at each position of the genome for tumor sample is 
calculated. Finally, the tumor read-depth is constructed by adding independent Poisson noise to each 
position of the genome. Figure 4.15 illustrates the pipeline of the simulator. 
 
 
Figure 4.14 Illustration of the spatial correlation of two adjacent data points in read-depth data. A 3-tuple (current_read_depth, 
next_read_depth, number_of_instances) represents how many times a specific combination of (current_read_depth, 
next_read_depth) is observed in the read-depth data. 
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Figure 4.15 Pipeline of simulator. 
 
To construct the BAF data, first, heterozygous SNPs are randomly distributed across the genome. It 
was assumed that there is one heterozygous SNP per 1500 base pair in the human genome and the 
BAF for each of these heterozygous SNPs was calculated. The BAF for a heterozygous SNP is the 
fraction of the number of alternate allele to the total number of reads at the position of the SNP. The 
number of alternate allele at the heterozygous SNP was calculated using a binomial distribution. The 
binomial distribution has two parameters: 𝑛 the number of trials (total number of reads at the position 
of the SNP) and 𝑝 the probability of success (the probability that a read is coming from the alternate 
allele). The parameter 𝑛 for each SNP is the read-depth at the position of the SNP in the genome. 
This value was extracted from the simulated normal read-depth at the position of the SNP. The 
probability of seeing an alternate allele at the position of a heterozygous SNP is 0.5. However, this 
probability changes because of changes in the copy number caused by aberrations. To calculate the 
parameter 𝑝, the two copy number tracks – explained earlier – was used. Once the number of alternate 
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allele was calculated, it was used to calculate the BAF value and then it was assigned to the current 
heterozygous SNP. 
Finally, ground truth is constructed using the two copy number tracks. This will be used in the 
evaluation of the developed tool. The simulated normal and tumor results were stored in a file with 
WIGGLE format. The BAF data was stored in a tab-separated file. The ground truth was also stored 
in file with SEG format for visualization purposes. Figure 4.15 illustrates the outputs of the simulator 
visualized in IGV. 
 
 
Figure 4.16  Simulated data visualized in IGV. 
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5. Results 
This chapter represents the results of running the developed tool over real and simulated data. First, 
some examples of the tool’s results visualized in IGV are presented. Furthermore, the results of the 
evaluation of the developed tool by running it over the simulated data are presented. Finally, the result 
of the benchmark against three other somatic copy number analysis tools and an explanation for each 
of the competing tools is presented. 
5.1. Examples 
The developed tool outputs a tab-delimited SEG file where each line in the file represents a detected 
segment, its position on the genome and the mean read-depth logratio of the segment. This file can 
be opened in IGV for visual inspection of the results. Figures 5.1 and 5.2 illustrate the results of the 
running of the tool over nine metastatic tumor samples obtained from different organs of a patient 
with metastatic prostate cancer. Figure 5.1 illustrates tumor protein p53 (TP53) copy number loss. 
Figure 5.2 illustrates the androgen receptor (AR) copy number amplification. 
Figure 5.3 represents the visualized results of running the tool over samples obtained from two 
cohorts of ERG-positive and ERG-negative patients. The results illustrate that many of the patients 
from the ERG-positive cohort have obtained a copy number loss of size around 3 Mbp between ERG 
and TMPRSS2 genes resulting in the formation of a TMPRSS2-ERG gene fusion. TMPRSS2-ERG 
gene fusion is a highly prevalent oncogenic alteration in prostate tumor cells and it leads to the 
androgenic induction of ERG expression (Tomlins, Rhodes et al. 2005, Furusato, Gao et al. 2008). 
 
 
Figure 5.1 Visualization of the results in IGV. TP53 copy number loss is observable in all the samples. 
 
Figure 5.2 Visualization of the results in IGV. AR copy number amplification is observable in all the samples. 
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Figure 5.3 Visualization of the results in IGV. A 3 megabase deletion between genes ERG and TMPRSS2 is observable in many of 
the ERG-positive samples. 
5.2. Results of Simulation Study 
As explained earlier a simulator capable of simulating the read-depth for both normal and tumor 
samples and BAF based on events such as deletion, amplification and copy-neutral LOH was 
developed. The simulated data was analyzed by the tool and the results of the segmentation were 
checked against the ‘ground truth’.  
A piece of code was written to compute the number of false positives, false negatives, and true 
positives based on the comparison of the results from the tool against the ground truth in order to 
calculate the false discovery ratio (FDR). False positive, in this context, refers to a situation where 
the tool places a breakpoint at a specific region of the genome where in reality there does not exist 
such a breakpoint. To calculate the number of false positives, the code checks whether for each 
detected breakpoints by the tools there is a breakpoint in the ground truth in a window of size 10 kbps 
centered on the detected breakpoint.     
False negative, in this context, refers to a situation where in reality there exists a breakpoint at a 
specific region of the genome and the tool fails to place a breakpoint at that region. To calculate the 
number of false negatives, the code checks whether for each breakpoint in the ground truth the tool 
has detected a breakpoint within a window of size 10 kbps centered on the ground truth breakpoint.  
True positive, in this context, refers to the actual breakpoint positions in the simulated genome. The 
number of true positives, in this context, can be directly extracted from the ground truth.  
Having calculated the number of false positives and true positives, one can calculate the false 
discovery rate, defined as: 
𝐹𝐷𝑅 =  
𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠
(𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝐹𝑎𝑙𝑠𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠 + 𝑁𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑇𝑟𝑢𝑒 𝑃𝑜𝑠𝑖𝑡𝑖𝑣𝑒𝑠)
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The lower the FDR, the better the tool is performing. The comparison of the results obtained from 
running the tool over simulated data against the ground truth revealed that, in general, the algorithm 
has a low false discovery rate of below 5%. 
5.2.1. Characterization of Sources of False Positives and False Negatives  
In order to characterize the sources of false positives and false negatives the output of the tool, the 
simulated read-depth data for both normal and tumor samples and the ground truth were loaded in 
IGV and the regions of the occurrence of the false positives and false negatives were inspected by 
eye. The visual inspection resulted in the identification of three sources of false negatives and false 
positives.  
The first source of false negatives was small segments (typically a few kbps) in the genome. If a 
segment was smaller than half of the size of the smallest double sliding window, it was not detected. 
As a result, tool is only capable of detecting copy number segments with the resolution of half of the 
smallest double sliding window.  
The second source of getting false negatives is caused by the random nature of the simulation. The 
simulator randomly places a breakpoint in the simulated tumor genome; as a result, there is a 
possibility for a scenario where some of the breakpoints in the ground truth fall in regions where there 
is not enough read-depth data. Consequently, the tool is not capable of detecting such breakpoints 
resulting in getting a false negative. This issue can be addressed in the future by redistributing the 
breakpoints, which are placed in regions of not enough data to other places with enough data.  
The third source of getting both false positives and false negatives is that on some occasions the tool 
places the breakpoint farther away (more than 5 kbps away but not much farther) from the ground 
truth since the tool does not have access to enough data to decide upon the exact position of the 
breakpoint. As a result, both false positive and false negative counts are increased. Figure 5.4 
illustrates such situation. The issue of determining the exact position of the breakpoint can be 
addressed, in the future, by an additional post-processing step where the sequencing reads will be 
used to pinpoint the exact breakpoint location up to a single-nucleotide resolution.  
5.3. Benchmark 
In order to benchmark the performance of the developed tool against competing tools a 
comprehensive search of the literature was performed and a list of copy number analysis tools was 
compiled. This list provides several pieces of information about each tool such as the name of each 
tool, the year in which each tool was published, the journal in which each tool was published, the 
inputs each tool requires, etc. Table 5.1 represents the list of 24 copy number analysis tools.   
 
Figure 5.4 Situation where a breakpoint is placed farther away from a ground truth breakpoint due to lack of data. 
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Table 5.1  List of copy number analysis tools. 
Name Year Journal Input Methods 
used  
Need of 
control 
Programming 
language 
Requires 
BAF 
Supported 
sequencing 
technology 
SegSeq 2009 Nature 
Methods 
BED Statistical 
testing, CBS 
Yes Matlab No Massively 
parallel 
sequencing 
readDepth 2011 PLOS ONE BED LOESS 
regression, 
CBS 
No R No Massively 
parallel 
sequencing 
CNVnator 2011 Genome Res. BAM Mean shift 
Algorithm 
No C No WGS 
RDXplorer 
(EWT) 
2009 Genome Res. BAM Statistical 
testing 
No R, Python No WGS 
CNAnorm 2012 Bioinformatics SAM, BAM, GC 
content data 
Linear 
regression, 
CBS 
Yes R No WGS 
rSW-seq 2010 BMC 
Bioinformatics 
Read-depth Smith-
Waterman 
Algorithm 
Yes C No WGS, Single-
end 
sequencing 
CNV-seq 2009 BMC 
Bioinformatics 
Hits Statistical 
testing 
Yes R, Perl No Shotgun 
sequencing 
cn.MOPS 2012 Nucleic Acids 
Res. 
BAM Mixture of 
Poisson, EM, 
CBS 
Multiple 
samples 
R, C++ No WES 
JointSLM 2011 Nucleic Acids 
Res. 
Data Matrix HMM, ML 
estimator, 
Viterbi 
algorithm 
Multiple 
samples  
R, Fortran No WGS 
GENSENG 2013 Nucleic Acids 
Res. 
Triplet of RD 
signal, GC 
content data, 
Mapability data 
HMM, 
Negative 
binomial 
regression 
No C++ No WGS 
PennCNV 2007 Genome Res. SNP array data HMM No Perl Yes SNP array 
DNAcopy 2004 Biostatistics aCGH data CBS - R No Microarray 
CLImAT 2014 Bioinformatics BAM, 
GC content data, 
Mapability data 
HMM No Matlab, C Yes WGS 
ASCAT 2010 PNAS logratio, BAF 
data 
statistical 
modelling 
optional R Yes SNP array 
GAP 2009 Genome Bio. SNP array data Pattern 
recognition 
No R Yes SNP array 
GPHMM 2011 Nucleic Acid 
Res. 
SNP array data, 
PFB data, GC 
data 
HMM No Matlab, C Yes SNP array 
MixHMM 2010 PLOS ONE SNP array data HMM No Python Yes SNP array 
OncoSNP 2010 Genome Bio. SNP array data Single 
Unified 
Bayesian 
Framework 
No Matlab Yes SNP array 
APOLLOH 2012 Genome 
Research 
Allelic counts, 
Copy number 
segment 
[HMMCopy] 
Non-
stationary 
HMM 
Yes Matlab Yes WGS 
ControlFREEC 2012 Bioinformatics BAM, SAM, 
Pileup, SNP 
data, 
Mapability data 
Lasso based Optional C++ Yes WGS, WES 
GIANT 2014 PLOS ONE SNP array data HMM Yes Matlab, C Yes SNP array 
Patchwork 2013 Genome 
Biology 
BAM, Pileup CBS Optional R Yes WGS 
SeqCNA 2014 BMC 
genomics 
SAM LOESS No R No WGS 
WaveCNV 2013 Bioinformatics Pileup Wavelet 
transform 
No Matlab, Perl Yes WGS 
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5.3.1. Overview of Competing Tools 
The criteria to choose the competing tools from the compiled list were that first, the tools were 
designed to work with WGS data. Second, the tools use BAF data in order to perform the copy number 
analysis; and finally, the tools were published in well-known journals or were recently published or 
they are popular among bioinformaticians. As can be seen from table 5.1, many of the available copy 
number analysis tools in this list are designed to work with SNP array data. Therefore, these tools 
were not considered as competing tools. Some of the tools were not publicly available at the time of 
compilation; these also were excluded from the list. Finally, some of the tools were not using the 
BAF data in order to perform the copy number analysis. In the end, three tools passed all the criteria. 
These tools were ControlFREEC (Boeva, Popova et al. 2012), Patchwork (Mayrhofer, DiLorenzo et 
al. 2013), and CLImAT (Yu, Liu et al. 2014). In what follows, these tools and their methodology are 
briefly described.  
5.3.1.1. ControlFREEC 
ControlFREEC (Control-FREE Copy number and allelic content caller) is a read-depth-based method 
for the detection of somatic copy number variations and LOH written in C++ programming language 
(Boeva, Popova et al. 2012a). ControlFREEC constructs the copy number and BAF profiles using the 
aligned reads and the genomic position data of known SNPs (retrieved from dbSNP database). 
Subsequently, ControlFREEC normalizes, segments, and analyzes the constructed profiles in order 
to determine the copy number and allelic content. ControlFREEC uses equally sized, non-overlapping 
windows in order to compute the read-depth ratios per each window. The use of control sample is 
optional. If a control sample is not available, ControlFREEC estimates a hypothetical read-depth for 
a given window using a polynomial function of the window’s GC content. However, if the control 
sample is available, it can distinguish somatic from the germline variants. In order to perform the 
segmentation, ControlFREEC determines the breakpoints using Least Absolute Shrinkage eStimatOr 
(LASSO) regression. One of the features of the ControlFREEC is its ability to evaluate and correct 
for the normal cell contamination, GC-content and mapability biases while constructing the copy 
number profile of a tumor genome (Boeva, Popova et al. 2012). However, the users should determine 
the sample ploidy. If ploidy is not known, it is suggested to run the program several times with 
possible ploidy values and compare the results (Liu, Morrison et al. 2013). 
5.3.1.2. Patchwork 
Patchwork is a read-depth-based method for performing allele-specific somatic copy number analysis 
(Mayrhofer, DiLorenzo et al. 2013). Patchwork is written in the R programming language. Patchwork 
automatically calculates the average ploidy and purity of the tumor cells, and therefore does not 
require a prior knowledge of average ploidy (as opposed to ControlFREEC) or tumor cell content. 
Patchwork starts by taking aligned reads in BAM format. Then, it performs GC-normalization 
followed by a positional normalization. After the normalization, Patchwork uses equally sized 
windows of size 10 kbps in order to compute the normalized read-depth for each of the windows. 
These are then used in order to segment the genome using the circular binary segmentation (CBS) 
algorithm where each segment is assigned an average normalized coverage. Furthermore, using 
SAMtools the single nucleotide variant data is extracted and informative heterozygous variants using 
a list of known SNPs (from dbSNP database) are identified. Using these, the allelic imbalance ratios 
are calculated and assigned to each segment. Subsequently, Patchwork visualizes the allelic 
imbalance ratio and the normalized coverage for genomic segments for each chromosome. Using 
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these visualizations, a user will be able to determine the parameters needed by Patchwork in order to 
assign allele-specific copy number to genomic segments or in other words, in order to determine 
different copy number states.  
5.3.1.3. CLImAT 
CLImAT (CNA and LOH Assessment in Impure and Aneuploid Tumors) suggested by Yu et al. (Yu, 
Liu et al. 2014) and written in C and Matlab programming language is a read-depth-based method 
for assessing the somatic copy number variation and LOH. CLImAT is also capable of estimating 
tumor impurity and ploidy. Furthermore, CLImAT does not require the use of a control sample. 
CLImAT starts by taking aligned reads in BAM format and a file containing the list of all known 
SNPs (retrieved from dbSNP database). SAMtools is used to extract read-depth data from the BAM 
file by counting the reads with starting position within 1000 base pair window centered on each of 
the known SNPs. Once the read-depth data is extracted, it is corrected for CG-content and mapability 
biases. Furthermore, BAF data for each SNP is calculated and normalized (using quantile 
normalization) in order to eliminate allelic bias. Allelic bias refers to the issue where most aligners 
prefer to align reads to reference allele than the alternative allele. Once the read-depth and BAF data 
are ready, CLImAT models them with an integrated HMM in order to infer somatic copy number 
variation, LOH, tumor ploidy, tumor cell content and tumor genotype.         
5.4. Sample Datasets 
In order to perform the benchmark of the developed tool against the competing tools, the BAM files 
for paired normal and tumor samples of 6 individuals diagnosed with prostate adenocarcinoma 
(PRAD) were selected from TCGA and downloaded from the CGHub (Appendix A contains the full 
name of the sample datasets used in this study). Each BAM file stores the aligned reads of a WGS 
experiment. 
5.5. Segmentation Results 
After downloading the sample datasets, parameters needed to run each of the tools were set based on 
the recommendations of the tool’s manual. Mostly, default values for parameters were used. The 
configuration files and parameters values used for running the tools can be found under appendices 
section (Appendix B).  
Different tools provide the results in different formats. In order to be able to inspect visually the 
results in IGV, the output of each tool were transformed into a SEG file. Following figures (figures 
5.5 – 5.16) represent the visualized results obtained from running the tools over six TCGA PRAD 
datasets. The difference in the heatmap coloring is because the developed tool (called Segmentum in 
the figures) and Patchwork assign a logarithmic average copy number to a segment but 
ControlFREEC and CLImAT assign an integral copy number to a segment. In addition, the results 
illustrate only the autosomes since CLImAT was unable to perform the copy number analysis of sex 
chromosomes at the time of performing the analysis.  
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Figure 5.5 Segmentation results obtained for sample G9_6338 (chromosomes 1-8). 
 
 
Figure 5.6 Segmentation results obtained for sample G9_6338 (chromosomes 9-22). 
 
 
Figure 5.7 Segmentation results obtained for sample G9_6342 (chromosomes 1-8). 
 
 
Figure 5.8 Segmentation results obtained for sample G9_6342 (chromosomes 9-22). 
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Figure 5.9 Segmentation results obtained for sample HI_7171 (chromosomes 1-8). 
 
 
Figure 5.10 Segmentation results obtained for sample HI_7171 (chromosomes 9-22). 
 
 
Figure 5.11 Segmentation results obtained for sample HC_7211 (chromosomes 1-8). 
 
 
Figure 5.12 Segmentation results obtained for sample HC_7211 (chromosomes 9-22). 
 
Figure 5.13 Segmentation results obtained for sample CH_5761 (chromosomes 1-8). 
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Figure 5.14 Segmentation results obtained for sample CH_5761 (chromosomes 9-22). 
 
 
Figure 5.15 Segmentation results obtained for sample HC_7212 (chromosomes 1-8). 
 
 
Figure 5.16 Segmentation results obtained for sample HC_7212 (chromosomes 9-22). 
 
Inspecting the results visually, it can be seen that there are genomic regions annotated as aberrant by 
all of the four tools, or there are cases where a genomic region is only picked by three, two or only 
one of the tools. In order to quantitatively measure the percentage of regions throughout the whole 
genome (except the sex chromosomes) annotated by either all four, three, two or only one of the tools, 
a small program was developed. First, the program breaks the genome into blocks of same size (100 
base pairs). Next, for each block, by inspecting the results from each of the tools the program checks 
whether the block is annotated as aberrant (either partially or completely) by any of the tools. If this 
is the case, it keeps track of the name of the tools that have annotated the block as aberrant. 
Subsequently, the program aggregates the results and calculates the percentages. Furthermore, the 
program calculates the pairwise concordances between tool-pairs. Pairwise concordance represents 
how much the results of two tools are concordant with each other. Following figures (figures 5.17 - 
5.22) illustrate the results from the program in the form of Venn diagrams. For instance, from the 
figure 5.17, it can be seen that 47.69% of the blocks were annotated by all the tools to be aberrant. 
From the same figure, it can be seen that around 28% of the blocks are annotated as aberrant solely 
by CLImAT.   
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Figure 5.17 Venn diagram of the results for sample G9_6338. 
 
 
Figure 5.18 Venn diagram of the results for sample G9_6342. 
 
 
Figure 5.19 Venn diagram of the results for sample HI_7171. 
 
 
Figure 5.20 Venn diagram of the results for sample HC_7211. 
 
 
Figure 5.21 Venn diagram of the results for sample CH_5761. 
 
 
Figure 5.22 Venn diagram of the results for sample HC_7212. 
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From the Venn diagrams results it can be observed that, on average, only 37.4% of the regions are 
annotated as aberrant by all four tools across six samples. In addition, from the Venn diagrams 
(excluding the Venn diagrams for samples CH_5761 and HC_7212), it can be seen that 
ControlFREEC and CLImAT tend to individually annotate as aberrant a large portion of the genome. 
For instance, in sample HC_7211, 24.52% of the annotated regions as aberrant by CLImAT are not 
detected by the other three tools. In the same sample, 21.38% of regions detected by ControlFREEC 
are not detected by the other three tools. At first, it might seem that these two tools are capable of 
detecting aberrations not detectable by the other two tools. However, one explanation for such 
behavior, as is evident from IGV visualizations, is that ControlFREEC and CLImAT tend to annotate 
the centromeres and telomeres as aberrant while the developed tool and Patchwork do not annotate 
these regions. 
In sample CH_5761, 62.56% of the annotated regions as aberrant by CLImAT are not detected by 
the other three tools. Looking at the visualizations for this sample shows that these regions are 
annotated as amplified by CLImAT. CLImAT reports an estimated average cancer DNA index for 
each sample. DNA index is a measure of the ploidy of cells. It is defined as the ratio between the 
DNA content of tumor cell and the DNA content of a normal cell. As a result, DNA index equal 1.0 
denotes a diploid cell and DNA indices below 0.96 or above 1.04 denote aneuploidy (Ormerod, 2008). 
The DNA index for sample CH_5761 estimated by CLImAT is 1.4228 suggesting that the whole 
genome has become aneuploid. However, it is difficult to determine whether this observation is real 
or not since the other three tools do not annotate this sample the same way as CLImAT does.  
The same observation can be seen for sample HC_7212. 65.83% of the annotated regions as aberrant 
by the developed tool are not detected by the other three tools. The understanding of the underlying 
reasons for such a behavior requires more in-depth deliberation. This issue will be addressed in future 
studies.  
As explained earlier, to see which pair of tools produces more concordant results, concordance 
measures were calculated for each tool-pair and for each sample. To calculate the concordance from 
the Venn diagram, the regions in the Venn diagram that are shared between both tools in a tool-pair 
is summed and then divided by the sum of the regions covered by both tools in a tool-pair. The 
following formula represents this mathematically: 
Pairwise concordance =  
⋂ 𝑝𝑎𝑖𝑟
⋃ 𝑝𝑎𝑖𝑟
 
Table 5.2 represents the list of concordance values for each tool-pair for each sample. As it can be 
observed from the list (except sample HC_7212), the results from Patchwork and Segmentum are 
producing the most concordant results.  
Table 5.2 List of pairwise concordances. 
 G9_6338 G9_6342 HI_7171 HC_7211 CH_5761 HC_7212 
Patchwork-Segmentum 94% 88% 78% 88% 97% 17% 
FREEC-Patchwork 69% 48% 68% 54% 87% 48% 
FREEC-Segmentum 68% 47% 68% 53% 87% 13% 
CLImAT-FREEC 58% 61% 65% 51% 34% 51% 
CLImAT-Patchwork 56% 59% 74% 51% 33% 70% 
CLImAT-Segmentum 55% 59% 69% 52% 33% 17% 
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6. Discussion 
The main objective of this study was to develop a tool capable of detecting genomic aberrations such 
as deletion, amplification and copy-neutral LOH events in the cancer genome using the WGS data. 
As explained in the literature review chapter, there are 4 main methods available in order to detect 
such aberrations. These four methods are (1) read-pair methods, (2) split-read methods, (3) sequence 
assembly methods, and (4) read-depth methods (Alkan, Coe et al. 2011).  In this study, read-depth 
method was used. The reason behind this choice was that this method is intuitive and it is the mostly 
adapted method by the research community in order to perform copy number analysis.   
One of the advantages of the developed tool over some other available CNA analysis tools is that it 
utilizes the BAF data in order to find the copy number segments. The use of BAF data not only 
improves the accuracy of copy number detection but also enables the identification of the copy-
neutral LOH events.  Tools that do not utilize such data are unable to detect copy-neutral LOH events. 
Even though there are many SNP array-based CNA analysis tools utilizing BAF data, there are not 
many WGS-based tools available. Another advantage of the developed tool is that it is fast. The 
developed tool is capable of performing the copy number analysis in less than two minutes.  
The developed tool has originally been designed to analyze WGS data and currently, it cannot be 
applied to WES data. This is because the sparse and non-uniform distribution of exons across the 
genome requires different types of data processing (Krumm, Sudmant et al. 2012). However, some 
tools such as ControlFREEC are capable of analyzing both WGS and WES data (Boeva, Popova et 
al. 2012).  
Currently, the developed tool requires a paired normal sample in order to correct for GC-content and 
mapability biases and to discriminate germline CNVs from the somatic CNAs. The assumption 
behind the requirement of a paired normal sample in order to correct for such biases is that GC-
content and mapability biases affect the normal and the tumor samples in a similar way. As a result, 
during the calculation of the read-depth ratios, these biases are implicitly corrected. However, the 
availability of many tumor samples without accompanying matched normal sample calls for the 
development of a general-purpose copy number analysis tool capable of performing bias correction 
without requiring the matched normal sample. There are already some strategies available in order to 
address this issue. For instance, Scheinin et al. (2014) are employing a binning strategy. In this 
approach, the genome is partitioned into fixed-sized bins and then the median read counts for all bins 
with the same combinations of GC and mapability are found. Next, a LOESS surface is fit through 
the medians and finally, the GC and mapability biases is corrected by dividing the raw counts by its 
corresponding LOESS value (Scheinin, Sie et al. 2014). 
The developed tool is capable of identifying copy number segments with the resolution of half of the 
size of the smallest double sliding window (typically a few kbps). As a result, in order to locate the 
exact position of segment boundaries up to a single-nucleotide resolution, the mapped sequencing 
reads can be inspected searching for the breakpoints in the reads. There are some tools available to 
perform such post processing of the results.  
Furthermore, the developed tool currently assigns a mean read-depth logratio to each segment, which 
is the average read-depth logratio of all the data points that fall into a segment. As a result, the 
developed tool is incapable of assigning an integral copy number value to a segment. However, some 
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HMM-based segmentation tools such as CLImAT are capable of assigning an integral copy number 
value to a segment by means of their hidden states where each hidden state is corresponding to an 
integral copy number (Klambauer, Schwarzbauer et al. 2012).  
Currently, the developed tool does not address the issues of normal cell contamination (tumor purity), 
tumor ploidy and tumor heterogeneity as opposed to tools such as Patchwork and CLImAT that are 
capable of inferring the tumor purity and tumor ploidy. Tumor heterogeneity refers to the observation 
that a tumor may be comprised of multiple clones of tumor cells. In principle, it is possible to infer 
the tumor purity, tumor ploidy and tumor heterogeneity from the observed read-depth logratios and 
BAF values. This is possible since there are only certain patterns of read-depth logratios and BAF 
values possible for a given copy number state and deviations from these patterns may lead to the 
inference of tumor ploidy, tumor purity and tumor heterogeneity (Liu, Morrison et al. 2013, Oesper, 
Mahmoody et al. 2013). For instance, in a triploid genomic region (i.e. copy number equal to 3) of a 
tumor sample with 100% of tumor purity, BAF values can be either 0, 0.33, 0.66 or 1 while for the 
same region with 50% of tumor purity, BAF values are shifted to 0, 0.415, 0.58 and 1.   
In the result section, it was observed that different tools produce different results and on average only 
37.4% of the regions was annotated as aberrant by all four tools across six samples. One can speculate 
few explanations for such observation. The difference in the results may be the byproduct of the 
underlying assumptions of different tools. Alternatively, it might be because of the parameter values 
that were set for the running of each tool. In this study, mostly (unless otherwise stated) the default 
parameter values were used assuming that the developers of the methods had better knowledge about 
the optimal parameter values (Appendix B contains the configuration files and the parameter values 
used in this study to run the tools). For instance, ControlFREEC requires the user to specify the ploidy 
of the samples and, in this study, to run this tool it was assumed that all the samples were diploid. 
The tool might have produced different results if prior knowledge about the ploidy of the samples 
was available.       
Even though in this study a simulator capable of producing the read-depth and BAF data for normal 
and tumor sample was developed, the format of the simulated data was not compatible with the input 
requirements of the competing tools. As a result, the simulated data was only used in order to evaluate 
the performance of the developed tool. One approach that some studies adopt in order to evaluate the 
result of their tools is to evaluate the obtained result against the result of a SNP array experiment on 
the same datasets. In this approach, the tumor samples are also assayed by SNP array technology. 
Then, the SNP array data is analyzed by a SNP array-based copy number analysis tool such as 
ASCAT (Van Loo, Nordgard et al. 2010). In this approach, the results of the copy number analysis 
from the SNP array analysis is considered as the ground truth. This approach for instance was used 
by CLImAT (Yu, Liu et al. 2014). However, this approach can introduce more costs to the study. 
Unfortunately, the SNP array data was not available for the TCGA PRAD data used in this study. 
Recently, there have been attempts to simulate HTS data that harbors all the existing biases in the 
sequencing data; however, these attempts have not yet been successful in capturing all the features of 
tumor genome. As a result, the unavailability of a comprehensive ground truth or gold standard to 
evaluate the results obtained from different CNA detection tools remains a challenge and until such 
option is not available it would be difficult to evaluate objectively how the tools are performing (Liu, 
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Morrison et al. 2013). Luckily, the research on developing simulated data is ongoing holding the 
promise that in the near future we will have access to such data.  
Finally, in this study, only Venn diagram and the concordance measure were used in order to assess 
the results from different tools. However, one can employ different evaluation criteria in order to 
ensure the robustness of the evaluation study.     
6.1. Further Research  
The future work can address some of the limitations in this work. For instance, this study can be 
furthered by developing a data analysis scheme capable of correcting for biases such as GC-content 
and mapability without the requirement of a paired normal sample. Furthermore, the tool can be 
expanded in order to address the issues of normal cell contamination (tumor purity), tumor ploidy 
and tumor heterogeneity. In addition, the developed simulator can be expanded in a way that it 
produces the data usable by other tools. Once these issues are addressed, one can tackle the problem 
of tumor evolution.  
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7. Conclusion 
In this study, the main aim was to develop a tool capable of detecting somatic copy number alterations 
such as deletion, amplification, and copy-neutral LOH in the tumor genome using WGS data. To do 
this, read-depth detection method was adapted. Read-depth methods detect the amplifications and 
deletions in the genome by examining respectively the increase and decrease in read-depth data 
extracted from BAM files. However, the read-depth data needs to be corrected for biases such as 
mapability and GC-content biases. In this study, it was assumed that the utilization of a matched 
normal sample in the calculation of the read-depth ratio of the tumor and normal sample would largely 
and implicitly correct for mapability and GC-content biases assuming that these biases affect both 
the normal and the tumor samples in a similar way. Furthermore, in order to detect genomic regions 
with copy-neutral LOH, the BAF data extracted from the BAM files were used. Finally, a double 
sliding window method was employed in order to segment the genome into either normal or aberrated 
regions harboring events such as deletion, duplication, or copy-neutral LOH based on both read-depth 
and BAF data.  
As a result, a fast and easy-to-use tool capable of performing copy number analysis was developed. 
The developed tool is capable of detecting amplifications, deletion and copy-neutral LOH. 
Furthermore, a simulator capable of simulating the read-depth and BAF data was developed. The 
simulated data was used to perform a simulation study. The results from the simulation study were 
first used to pinpoint the issues in the implementation and to improve the performance of the tool in 
terms of sensitivity and specificity. Furthermore, the results from the simulation study showed that 
the developed tool was performing well.  
In addition to the simulation study, a benchmark was performed where the developed tool along with 
three other competing tools analyzed six prostate adenocarcinoma samples downloaded from the 
cancer genome atlas (TCGA). The results from the benchmark showed that the developed tool was 
capable of producing comparable results in comparison to other competing tools. Finally, in the 
discussion chapter the limitations of the developed tool such as its inability to infer the tumor purity 
and ploidy was addressed and further possible research to improve the tool in the future was outlined. 
As explained earlier, CNAs and copy-neutral LOH are two important drivers of genomic instability 
associated with cancer and accurate detection of these aberrations holds the promise to increase our 
knowledge of the underlying processes of cancer by identifying novel cancer related oncogenes and 
tumor suppressor genes. This consequently may help in finding new ways in treating cancer. 
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Appendices  
In this section the appendices for this study is presented. Appendix A contains the complete name of 
the TCGA PRAD samples used for the benchmark. Appendix B presents the parameter values and 
the configuration files used for the running of the competing tools. Finally, appendix C represents the 
sets of commands in the Pypette package used to extract the read-depth and BAF data from BAM 
files required by the developed tool.   
 
Appendix A. Sample Dataset Names 
This appendix provides the complete name of the downloaded TCGA PRAD datasets from CGHub. 
 
TCGA-G9-6338-01A-12D-1957_130222_SN1222_0174_BC1RNEACXX_s_5_rg.sorted.bam    G9_6338_t 
TCGA-G9-6338-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_6_rg.sorted.bam   G9_6338_n 
TCGA-HC-7211-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_2_rg.sorted.bam     HC_7211_t 
TCGA-HC-7211-11A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_3_rg.sorted.bam     HC_7211_n 
TCGA-G9-6342-01A-11D-1957_130222_SN1222_0174_BC1RNEACXX_s_7_rg.sorted.bam  G9_6342_t 
TCGA-G9-6342-10A-01D-1957_130222_SN1222_0174_BC1RNEACXX_s_8_rg.sorted.bam  G9_6342_n 
TCGA-HI-7171-01A-12D-2111_130607_SN590_0232_BD26R5ACXX_s_7_rg.sorted.bam  HI_7171_t 
TCGA-HI-7171-10A-01D-2111_130607_SN590_0232_BD26R5ACXX_s_8_rg.sorted.bam  HI_7171_n 
TCGA-HC-7212-01A-11D-2111_130517_SN590_0230_AD24B4ACXX_s_4_rg.sorted.bam  HC_7212_t 
TCGA-HC-7212-10A-01D-2111_130517_SN590_0230_AD24B4ACXX_s_5_rg.sorted.bam  HC_7212_n 
TCGA-CH-5761-01A-11D-1572_130103_SN1222_0166_BD1K7EACXX_s_7_rg.sorted.bam  CH_5761_t 
TCGA-CH-5761-11A-01D-1572_130103_SN1222_0166_BD1K7EACXX_s_8_rg.sorted.bam  CH_5761_n 
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Appendix B. Parameters and Configuration Files 
Under this appendix the parameter settings and content of the configuration files used to run the 
competing tools is presented. 
ControlFREEC 
ControlFREEC requires a SNP file and a configuration file in order to run. The SNP file was 
downloaded from https://xfer.curie.fr/get/QKFgcU5caZd/hg19_snp138.SingleDiNucl.1based.txt.gz 
Here, the content of the configuration file for each of the samples is presented.  
G9_6338 
[general] 
chrFiles = /data/csb/datasets/tcga_prad/wgs/hg19_broad_variant 
chrLenFile = /home/afyounia/controlFREEC_run/hg19.chrom.sizes 
coefficientOfVariation =  0.05 
#window = 5000 
contaminationAdjustment = TRUE 
intercept = 1                            
outputDir = /home/afyounia/controlFREEC_run/results/g9_6338_cv 
ploidy = 2 
samtools = samtools 
sex = XY 
numberOfProcesses = 5 
 
[sample] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/G9_6338_t.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[control] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/G9_6338_n.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[BAF] 
SNPfile = /data/csb/datasets/tcga_prad/wgs/snp_file/hg19_snp138_1based_nochr_FREEC.txt 
 
HC_7211 
[general] 
chrFiles = /data/csb/datasets/tcga_prad/wgs/hg19_broad_variant 
chrLenFile = /home/afyounia/controlFREEC_run/hg19.chrom.sizes 
coefficientOfVariation =  0.05 
#window = 5000 
contaminationAdjustment = TRUE 
intercept = 1                              
outputDir = /home/afyounia/controlFREEC_run/results/hc_7211_cv 
ploidy = 2 
samtools = samtools 
sex = XY 
numberOfProcesses = 5 
 
[sample] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/HC_7211_t.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[control] 
mateFile = /data/csb/datasets/tcga_prad/wgs/pileups_freec/HC_7211_n.pileup.gz 
inputFormat=pileup 
mateOrientation=FR 
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[BAF] 
SNPfile = /data/csb/datasets/tcga_prad/wgs/snp_file/hg19_snp138_1based_nochr_FREEC.txt 
 
G9-6342 
[general] 
chrFiles = /data/csb/datasets/tcga_prad/wgs/hg19_broad_variant 
chrLenFile = /home/afyounia/controlFREEC_run/hg19.chrom.sizes 
coefficientOfVariation =  0.05 
#window = 5000 
contaminationAdjustment = TRUE 
intercept = 1                              
outputDir = /home/afyounia/controlFREEC_run/results/g9_6342_cv 
ploidy = 2 
samtools = samtools 
sex = XY 
numberOfProcesses = 5 
 
[sample] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/G9_6342_t.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[control] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/G9_6342_n.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[BAF] 
SNPfile = /data/csb/datasets/tcga_prad/wgs/snp_file/hg19_snp138_1based_nochr_FREEC.txt 
 
HI-7171 
[general] 
chrFiles = /data/csb/datasets/tcga_prad/wgs/hg19_broad_variant 
chrLenFile = /home/afyounia/controlFREEC_run/hg19.chrom.sizes 
coefficientOfVariation =  0.05 
#window = 5000 
contaminationAdjustment = TRUE 
intercept = 1                              
outputDir = /home/afyounia/controlFREEC_run/results/hi_7171_cv 
ploidy = 2 
samtools = samtools 
sex = XY 
numberOfProcesses = 5 
 
[sample] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/HI_7171_t.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[control] 
mateFile = /data/csb/datasets/tcga_prad/wgs/pileups_freec/HI_7171_n.pileup.gz 
inputFormat=pileup 
mateOrientation=FR 
 
[BAF] 
SNPfile = /data/csb/datasets/tcga_prad/wgs/snp_file/hg19_snp138_1based_nochr_FREEC.tx 
 
HC-7212 
[general] 
chrFiles = /data/csb/datasets/tcga_prad/wgs/hg19_broad_variant 
chrLenFile = /home/afyounia/controlFREEC_run/hg19.chrom.sizes 
coefficientOfVariation =  0.05 
#window = 5000 
contaminationAdjustment = TRUE 
 58 
intercept = 1                              
outputDir = /home/afyounia/controlFREEC_run/results/hc_7212_cv_2 
ploidy = 2 
samtools = samtools 
sex = XY 
numberOfProcesses = 5 
 
[sample] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/HC_7212_t.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[control] 
mateFile = /data/csb/datasets/tcga_prad/wgs/pileups_freec/HC_7212_n.pileup.gz 
inputFormat=pileup 
mateOrientation=FR 
 
[BAF] 
SNPfile = /data/csb/datasets/tcga_prad/wgs/snp_file/hg19_snp138_1based_nochr_FREEC.txt 
 
CH-5761 
[general] 
chrFiles = /data/csb/datasets/tcga_prad/wgs/hg19_broad_variant 
chrLenFile = /home/afyounia/controlFREEC_run/hg19.chrom.sizes 
coefficientOfVariation =  0.05 
#window = 5000 
contaminationAdjustment = TRUE 
intercept = 1                              
outputDir = /home/afyounia/controlFREEC_run/results/ch_5761_cv 
ploidy = 2 
samtools = samtools 
sex = XY 
numberOfProcesses = 5 
 
[sample] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/CH_5761_t.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[control] 
mateFile =  /data/csb/datasets/tcga_prad/wgs/pileups_freec/CH_5761_t.pileup.gz  
inputFormat=pileup 
mateOrientation=FR 
 
[BAF] 
SNPfile = /data/csb/datasets/tcga_prad/wgs/snp_file/hg19_snp138_1based_nochr_FREEC.txt 
     
Patchwork 
Patchwork, in order to run, requires a reference genome. The documentation recommends creating a 
reference genome using 𝑝𝑎𝑡𝑐ℎ𝑤𝑜𝑟𝑘. 𝑐𝑟𝑒𝑎𝑡𝑒𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒() function with three normal BAM files. 
The following normal sample BAM files were used in order to create the reference genome: 
G9_6338_n, HI_7171_n and CH_5761_n (refer to appendix A for the complete sample names).       
Furthermore, Patchwork uses 𝑝𝑎𝑡𝑐ℎ𝑤𝑜𝑟𝑘. 𝑐𝑜𝑝𝑦𝑛𝑢𝑚𝑏𝑒𝑟𝑠() function in order to assign copy number 
and allele ratio for each of the segments. This function receives some parameters. These parameters 
are cn2, delta, het, and hom. In order to set the parameters, the user is required to interpret one of the 
chromosomal plots generated by the 𝑝𝑎𝑡𝑐ℎ𝑤𝑜𝑟𝑘. 𝑝𝑙𝑜𝑡() function. cn2 denotes the position of copy 
number 2 in the plot. delta denotes the difference between two copy numbers on the coverage axis. 
het denotes the position of heterozygous copy number 2 on the allelic imbalance axis. Finally, hom 
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denotes the position of homozygous, LOH, copy number 2 on the allelic imbalance axis. The 
Patchwork documentation (available at: http://patchwork.r-forge.r-project.org) provides an example 
illustrating how these parameter values are extracted from the plot. Figure B.1 represents this example 
plot. From this example figure, the following parameter values can be extracted from the plot: 𝒄𝒏𝟐 =
 0.8, 𝒅𝒆𝒍𝒕𝒂 =  0.28, 𝒉𝒆𝒕 =  0.21 and 𝒉𝒐𝒎 =  0.79. In this study, the same procedure was used in 
order to extract the parameter values for the six TCGA PRAD samples.     
 
CLImAT 
There are two steps in performing copy number analysis using CLImAT. First, the read-depth data 
need to be extracted from the BAM files using DFExtract tool. After having extracted the read-depth 
data, in order to perform the copy number analysis CLImAT is used.  
DFExtract requires a SNP file and a mapability file in order to extract the read-depth data. The SNP 
file was downloaded from 
http://bioinformatics.ustc.edu.cn/CLImAT/download.html.  
The recommended mapability (wgEncodeCrgMapabilityAlign36mer.bw) file was downloaded from  
http://hgdownload.cse.ucsc.edu/goldenPath/hg19/encodeDCC/wgEncodeMapability/.  
Furthermore, some parameter values need to be passed to the DFExtract. Table B.1 lists the default parameter 
values for running DFExtract. In addition, CLImAT requires a configuration file in order to run. Table 
B.2 lists the default parameter values used to create the configuration file:  
 
 
Figure B.1 Extraction of parameter values from the plot created by Patchwork. 
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Table B.1 Default parameter values used for running DFExtract. 
Options Description Default value 
-w, --window set the size of windows 1000 
-Q, --baseQ threshold value for base quality 10 
-q, --mapQ threshold value for mapping quality 20 
-d, --minDepth minimum read-depth for a position to be considered 10 
 
 
Table B.2 Default parameter values used for running CLImAT. 
Parameters Description Default value 
minDepth minimum read-depth for a position to be considered 10 
maxDepth maximum read-depth for a position to be considered 300 
minGC minimum GC-content for a position to be considered 0 
minMapScore minimum mapability score for a position to be considered 0 
maxMapScore maximum mapability score for a position to be considered 0.98 
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Appendix C. Extraction of Read-depth and BAF Data from BAM Files using Pypette Package 
 
In order to extract the read-depth data from BAM files following command is used:  
coverage tiled <bam_file> <window_size> [-s N] [-q N] [-S|-1|-2] [-P|-M] 
     
Options: 
  -q --quality=N    Minimum alignment quality [default: 10]. 
  -s --step=N       Step size for window placement [default: window size / 2]. 
  -S --single       Use all reads for coverage calculation, not just paired. 
  -P --plus         Calculate coverage only for the plus strand. 
  -M --minus        Calculate coverage only for the minus strand. 
 
 
In order to extract the BAF values from BAM files, the following commands are used sequentially: 
variant call <genome_fasta> <bam_files>... [-r REGION] [--ref=N:R] [--hetz=N:R]         
[--homz=N:R] [-q N] [-Q SAMPLES] [--keep-all] 
 
variant keep samples <vcf_file> <regex> 
 
variant heterozygous bases <vcf_file> <pos_file> 
 
variant discard samples <vcf_file> <regex> 
 
variant allele fractions <vcf_file> <pos_file> 
     
Options: 
  -r <region>       Restrict analysis to chromosomal region 
  -q N              Minimum mapping quality score [default: 10] 
  -Q SAMPLES        Samples for which mapping quality is ignored [default: ] 
  --ref=N:R         Minimum evidence for homozygous reference [default: 8:0.9] 
  --hetz=N:R        Minimum evidence for heterozygous [default: 4:0.25] 
  --homz=N:R        Minimum evidence for homozygous alt [default: 4:0.8] 
  --keep-all        Show sites even if they are all homozygous reference 
 
